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Abstract
Cognitive Processing Therapy (CPT) has been empirically validated as an efficacious
treatment for Posttraumatic Stress Disorder (PTSD) (Resick, Nishith, Weaver, Astin, &
Feuer, 2002; Cloitre, 2009). However, a deficiency of affect regulation skills may act as a
barrier to the successful implementation of CPT in some cases, as CPT does not contain a
module that directly addresses affectivity. The current study examined the relationship
between affectivity and CPT by utilizing neuroimaging methodology to assess brain
regions consistent with an affect regulation model of PTSD. Thirty-eight female
interpersonal trauma survivors with PTSD received CPT, participating in assessment and
scanning sessions at pre-treatment and post-treatment. The results indicated that CPT
does indeed address affectivity over the course of treatment, with treatment completers
reporting significantly greater positive affectivity (PA) and reduced negative affectivity
(NA) post-treatment. Significant differences were also observed between the treatment
completion and treatment dropout groups, such that individuals who dropped out of
treatment exhibited lower levels of PA at pre-treatment. With regard to brain structure at
pre-treatment, PA was found to exhibit a significant positive association with volume of
the right medial frontal gyrus. The relationship between brain function and affectivity
was also examined in treatment completers at pre- and post-treatment. The results and
implications of this project are discussed.
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Introduction
Posttraumatic Stress Disorder (PTSD) is a psychiatric condition that develops
subsequent to the experience of a traumatic event involving “actual or threatened death,
serious injury, or sexual violence” (DSM-5, American Psychiatric Association, 2013, p.
271). The course of PTSD is often chronic and debilitating, as evidenced by high rates of
distress, diagnostic comorbidity, disability, and suicide. However, not all individuals
exposed to a traumatic event will develop PTSD. Of the 81.7% of individuals who
experience a traumatic event during their lifetime (Sledjeski, Speisman, & Dierker,
2008), only 15-25% of these individuals are estimated to meet diagnostic criteria for
PTSD (Breslau et al., 1998; Kessler et al., 1995; Creamer, Burgess, & McFarlane, 2001).
Thus, posttraumatic symptoms will remit with the passage of time for most trauma
survivors. For others, PTSD symptoms persist, as lifetime prevalence rates range from
6.4-6.8% (Kessler, Chiu, Demler, Merikangas, & Walters, 2005; Pietrzak, Goldstein,
Southwick, & Grant, 2011).
Psychotherapy is considered to be the first-line treatment option for the symptoms
of PTSD, which include intrusion symptoms, avoidance, negative alterations in
cognitions and mood, and alterations in arousal and reactivity (DSM-5, American
Psychiatric Association, 2013). Specifically, cognitive processing therapy (CPT), a
variant of cognitive behavioral therapy (CBT) for PTSD, has been empirically validated
as an efficacious treatment (Resick, Nishith, Weaver, Astin, & Feuer, 2002; Cloitre,
2009). Empirical investigations have yielded data that CPT for PTSD is demonstrably
more effective in providing clinically significant outcomes than treatment as usual or
unstructured therapy modalities (Cloitre, 2009). In comparison to other forms of CBT for
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PTSD, CPT exhibits equivalent efficacy in treating PTSD, and in contrast to prolonged
exposure (PE), is additionally effective in reducing guilt related cognitions (Resick,
Nishith, Weaver, Astin, & Feuer, 2002). Specific modules within CPT have
demonstrated efficacy for treating PTSD as well. For example, Resick, Galovski,
Uhlmansiek, et al. (2008) found that CPT, cognitive therapy, and exposure through
written accounts each yielded significant symptom reductions in both PTSD and
depressive symptomatology in a dismantling trial. The examination of such mechanisms
has been an important step in the establishment of CPT as a preferred psychotherapy
option for PTSD.
Common to variants of CBT, CPT addresses both cognitive and behavioral
contributions to the manifestation of PTSD. CPT assumes PTSD to be a fear-based
disorder that develops from maladaptive learning in response to exposure to threatening,
traumatic stimuli (Lissek & Grillon, 2012). This exposure leads to a conditioned fear
response thought responsible for PTSD symptoms. CPT recognizes that the formation of
mental representations subsequent to a traumatic experience are comprised of feared
stimuli, learned responses to the stimuli, and cognitive attributions about the event (Foa
& Kozak, 1986; Resick & Schnicke, 1993). Processing the meaning attached to a trauma
is considered to be integral to the resolution of the disorder.
However, there is an expansive body of literature that has established affect
dysregulation as central to the conceptualization of PTSD, deemphasizing fear as the sole
emotional component (Wolfsdorf & Zlotnick, 2001; Frewen & Lanius, 2006; Watson,
O’Hara, & Stuart, 2008; Marshall-Berenz et al., 2011). This change in conceptualization
is reflected by the expansion of symptom clusters from three to four in the diagnostic
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criterion of PTSD in the recent iteration of the Diagnostic and Statistical Manual of
Mental Disorders, 5th Edition, (DSM-5, American Psychiatric Association, 2013). The
fourth symptom cluster, defined as “negative alterations in cognitions and mood
associated with the traumatic event(s), beginning or worsening after the traumatic
event(s) occurred” (American Psychiatric Association, 2013), is acknowledgment of the
disruption of affective systems in PTSD. A deficiency of affect regulation skills may act
as a barrier to the successful implementation of CPT in some cases, as CPT does not
contain a module that directly addresses affect dysregulation. The consideration of
affectivity can potentially address the limitations noted in the current CPT model.
Affectivity
According to Watson & Clark (1984), affectivity is comprised of a two factorstructure that includes negative affect (NA) and positive affect (PA). The term “affect”
was adopted to classify the underlying factor structure of the general experience of mood
(Watson & Tellegen, 1985). NA represents a dispositional mood dimension of subjective
distress. The construct reflects extensive individual differences in self-concept and
emotionality. The experience of NA is thought to subsume a variety of aversive mood
states including anger, contempt, disgust, guilt, and nervousness (Watson, Clark, &
Tellegen, 1988). NA is also associated with the pervasive experience of affective states of
scorn, revulsion, self-dissatisfaction, a sense of rejection, and to a degree, sadness.
However, at its inception, NA was considered to be unrelated to the emotion of fear
(Watson & Clark, 1984). PA is defined as “pleasurable engagement with the
environment” and encompasses the tendency to experience positive emotions and mood
states (Watson, Clark, & Carey, 1988). PA has been considered an integral component to
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the experience of depression, given that depressed individuals tend to report anhedonia
and diminished positive mood and emotions (Watson, Clark, & Tellegen, 1988).
With consideration of the two-factor structure of mood, the experience of NA
does not imply that an individual cannot experience positive mood or emotions and vice
versa. In fact, there is an abundance of evidence that establishes NA and PA as
orthogonal constructs (Watson & Tellegen, 1985; Watson, Clark, & Carey, 1988; Brown,
Chorpita, & Barlow, 1998). Moreover, PA seems to be representative of an individual’s
level of engagement with the environment and less related to subjective levels of distress.
This distinction between these two dimensions is important as it implies that both PA and
NA are not simply reactive in nature. NA can still manifest in the presence of pleasurable
engagement with the environment and the absence of any overt stressors (Watson &
Clark, 1984).
The above conceptualization of affectivity characterizes the construct as
containing both state and trait features. These characteristics are not mutually exclusive
and coexist as a function of stimulus and time. For example, trait NA, often referred to as
negative affectivity, represents the consistent, sustained experience of negative emotion
and mood over time that occurs independent of specific cues. Conversely, state NA is an
immediate emotional response that is temporally bound and related to a particular
stimulus (Clark & Watson, 1991; Meriau et al., 2009). An individual’s trait NA can
interact with their temporal, state NA response to an immediate stressor in the
environment. State NA is a natural part of the human emotional experience, but pervasive
individual differences in mood and self-concept accounted for by negative affectivity can
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exert a powerful influence over transient anxiety, under both neutral and stressful
conditions.
The relationship between Negative Affectivity and PTSD
Symptoms within DSM-5 criterion D for PTSD include exaggerated negative
beliefs and expectations, distorted cognitions that manifest notions of self-blame, and the
persistent experience of a negative emotional state (e.g., fear, horror, anger, guilt or
shame; American Psychiatric Association, 2013). These symptoms are characteristics of
increased negative affectivity (NA). Generally speaking, NA acts as a predisposing factor
for several types of anxiety disorder pathologies (Brown, Chorpita, & Barlow, 1998).
PTSD, however, is unique in that it also requires the experience of a traumatic event to be
diagnosed, a feature that accounts for the heterogeneous presentation of the disorder.
Despite the often complex presentation of posttraumatic symptoms, NA has still been
found to act as a predicting variable for the onset of PTSD (Frazier et al., 2011). For
example, a study of NA in youths 17 months before the landfall of Hurricane Katrina
found that preexisting NA significantly predicted the development of posttraumatic stress
symptoms post-disaster (Weems et al., 2007). In a similar study, Souza and colleagues
(2008) found that NA was a risk factor for the development of PTSD symptoms in United
Nations peacekeepers in Haiti. They also demonstrated that NA interacts with intensively
stressful situations to exacerbate PTSD symptoms, suggesting that individuals with
greater NA may experience worsened posttraumatic reactions (Souza et al., 2008).
NA appears to be a pervasive risk factor for the development of PTSD, regardless
of the type of trauma experienced. NA consistently predicts the development of PTSD in
both men and women across different traumatic events, including a factory explosion and
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physical assaults (Christiansen & Elklit, 2008). NA has also been found to predict PTSD
symptoms in combat veterans who fought in Afghanistan (Rademaker et al., 2011) and
Iraq (Ferrier-Auerbach et al., 2010). Brown and colleagues (2014) observed that selfreported NA was the strongest predictor of PTSD symptom severity and, specifically, reexperiencing symptoms in a sample of female interpersonal trauma survivors. Further
evidence suggests that a disposition of high NA may interact with a traumatic event in
such a way that predisposes an individual to the manifestation of PTSD (Pederson &
Denollet, 2004).
The maintenance of PTSD symptoms is often explained as a function of
avoidance by CPT (Resick & Schnicke, 1992). Indeed, it has been demonstrated that
individuals experiencing high levels of trait NA exhibit the tendency to avoid threatening
stimuli (Kunst, Bogaerts, & Winkel, 2011). Within the context of PTSD, high NA may
cause an individual to avoid any reminder of the traumatic event. This notion is further
supported by the fact that negative interpretations of intrusive memories and rumination,
which are characteristics of high NA, exacerbate cognitive avoidance and depression
symptom severity (Starr & Moulds, 2006). Additionally, acceptance of the traumatic
event has been associated with non-pathological responses to trauma and decreased NA
(Shallcross et al., 2010). High NA may impede subjective acceptance of a traumatic
experience and instead facilitate further perseveration on the traumatic event. Perceptual
consequences of high NA include negative self-concept and negative attentional bias,
which likely influence notions of self-blame and inadequacy often experienced by
survivors of traumatic events (Miller & Porter, 1983).
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A factor analysis of cumulative PTSD symptoms yielded a moderate factor
loading on a non-specific general distress component identified as NA (Watson, 2005).
Additional findings have indicated that NA is primarily associated with the dysphoria
factor of PTSD (Milanak & Berenbaum, 2009). NA has been found to predict PTSD
symptom severity, such that higher levels of NA are associated with higher levels of
PTSD cluster scores (Brown, Bruce, Buchholz, Mueller, Hu, & Sheline, 2014; Post,
Zoellner, Youngstrom, & Feeny, 2011; Blanchard, Buckley, Hickling, & Taylor, 1998).
The relationship between NA and the distress factor associated with PTSD is notable as it
provides insight to symptom severity and conditions characterized by the pervasive
experience of NA that are often comorbid with PTSD. For example, multiple studies have
shown lifetime comorbidity rates of PTSD and Major Depressive Disorder (MDD) of
approximately 50% and higher (King-Kallimanis, Gum, & Kohn, 2009; Nixon, Resick, &
Nishith, 2004; Hankin, Spiro, Miller, & Kazis, 1999; Blanchard et al., 1998; Boudreaux
et al., 1998; Kessler et al., 1995; Shore, Vollmer, & Tatum, 1989). PTSD also exhibits a
16.8% lifetime comorbidity rate with Generalized Anxiety Disorder (Kessler et al., 1995)
and a 30.2% current comorbidity rate with Borderline Personality Disorder (Pagura et al.,
2010). The substantial overlap of symptoms between these disorders is also proposed to
be attributed to the common experience of NA (Clark & Watson, 1991; Mineka et al.,
1998; Watson, 2005).
The relationship between Positive Affectivity and PTSD
Positive affect has rarely been examined within a PTSD conceptualization,
despite DSM-5 diagnostic criteria for PTSD including symptoms of “markedly
diminished interest or participation in significant activities” and “persistent inability to
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experience positive emotions (e.g., inability to experience happiness, satisfaction, or
loving feelings)” in criterion D, the affective symptom cluster (American Psychiatric
Association, 2013, p. 272). However, a few studies have incorporated PA into their
analyses regarding PTSD. One study demonstrated that women with PTSD reported
fewer positive trait-descriptors as self-descriptive and experienced less positive affect in
response to viewing pictures of themselves while listening to trait adjectives than women
without PTSD (Frewen et al., 2011). Also, it has been reported that individuals with
comorbid PTSD and MDD exhibit lower levels of PA than individuals solely diagnosed
with PTSD, and this result is consistent with literature regarding the compounding effects
of comorbid disorders (Post, Zoellner, Youngstrom, & Feeny, 2011).
Affect Regulation Theory and the psychopathology of PTSD
Healthy affect regulation is proposed to occur when an individual is able to utilize
strategies prior to the full activation of their emotional response, like cognitive
reappraisal (John & Gross, 2004). Cognitive reappraisal enhances the ability to construe a
situation from multiple perspectives, subsequently altering the instinctual emotional
response. Alternatively, research demonstrates that strategies accessed following the full
activation of an emotional response, like expressive suppression, tend to be less
successful in quelling negative affect (John & Gross, 2004). Simply stated, expressive
suppression involves the effortful inhibition of an ongoing emotional response. The
consistent usage of expressive suppression to manage emotions is thought to contribute to
persistent affect dysregulation (John & Gross, 2004), as the concept is essentially a shortterm avoidance strategy.
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Affect dysregulation is defined as the “inability to adaptively manage or tolerate
intense emotions” (Wolfsdorf & Zlotnick, 2001). This dysregulation can include the
overwhelming or uncontrollable experience of anger, sadness, guilt, anxiety, or shame.
Behavioral manifestations of affect dysregulation encompass angry or irritable outbursts,
frequent interpersonal conflict, impulsive or risky behavior, self-injury, and suicidality
(van der Kolk et al., 1996; Wolfsdorf & Zlotnick, 2001). There is evidence to suggest that
affect dysregulation occurs subsequent to the experience of a traumatic event, regardless
of whether the diagnostic criteria for PTSD are met (New, Fan, Murrough, et al., 2009;
Dale, Carroll, Galen, et al., 2009). Also, when the diagnostic criteria for PTSD are met,
affect dysregulation is typically experienced to varying degrees, regardless of trauma type
(Ehring & Quack, 2010). While a traumatic event can bring about affect regulation
difficulties, prior affect dysregulation can also be exacerbated by a trauma and increase
risk for the development of PTSD (Cloitre et al., 2005; van der Kolk et al., 2005).
Indeed, convergent evidence indicates that individuals with PTSD experience
substantial difficulty regulating affect. One study observed that veterans of combat
trauma generally experience difficulty processing and regulating emotional stimuli (Wolf,
Miller, & McKinney, 2009). Other research has found that traumatized individuals have
increased difficulty with the ability to identify and label their own emotional states (i.e.,
alexithymia) as compared to non-traumatized controls (Cloitre, Scarvalone, & Difede,
1997; Monson et al., 2004; McLean, Toner, Jackson, Desrocher, & Stuckless, 2006).
Traumatized individuals also exhibit a greater fear of negative emotions and more
difficulty tolerating and regulating these emotions in comparison to non-traumatized
control subjects (Briere & Rickards, 2007; Tull, Jakupcak, McFadden, & Roemer, 2007).
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A study by van der Kolk and colleagues (1996) found a strong positive relationship
between PTSD and affect dysregulation. This study also demonstrated that individuals
with current PTSD tend to report more difficulties modulating affect than individuals
with a history of PTSD or trauma-exposed control subjects without a history of PTSD.
However, individuals with a history of PTSD also continued to report disruptions of
affect as well compared to healthy controls, suggesting the persistence of affect
dysregulation in the absence of current PTSD symptoms (van der Kolk et al., 1996).
Research regarding affect dysregulation and PTSD has led to the use of
neuroimaging techniques as a neurobiological indicator of cognitive and emotional
disruption. Many of the same brain areas implicated by the fear circuitry model of PTSD,
including the amygdala, hippocampus, and medial prefrontal cortex (mPFC), demonstrate
dysregulation in response to affective stimuli unrelated to feared reminders of the
traumatic event. For example, in one study using Positron Emission Tomography (PET
technology), individuals with PTSD exhibited decreased blood flow to the orbitofrontal
cortex, anterior cingulate (ACC), mPFC, left hippocampus, and the fusiform gyrus during
retrieval of emotionally valenced word pairs in comparison to healthy controls. Blood
flow unexpectedly increased to the posterior cingulate, left inferior parietal cortex, and
left middle frontal gyrus, suggesting a disruption of normal emotion regulation in this
sample (Bremner et al., 2003).
Several recent functional magnetic resonance imaging (fMRI) studies corroborate
findings in these brain regions in response to emotional stimuli. In addition to its function
of perceiving threatening stimuli, the amygdala influences the generation of sustained
emotional responses (Davis, 1992; Davis & Whalen, 2001; Liberzon et al., 1999), which
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theoretically can be considered the “source” of dysregulated affect. Convergent evidence
indicates that the amygdala is hyperresponsive to both emotional and threat-related
stimuli in individuals with PTSD (Liberzon, Britton, & Phan, 2003; Armony, Corbo,
Clement, & Brunet, 2005; Bryant et al., 2008). However, in comparison to other
disorders of fear circuitry, hyperactivation of the amygdala was found more frequently in
social anxiety disorder and specific phobia than in PTSD (Etkin & Wager, 2007). This
finding suggests that fear circuitry is less integral to the conceptualization of PTSD than
other disorders of fear.
The mPFC, a central component of fear circuitry, exhibits consistent
hypoactivation in response to threat-related stimuli in individuals with PTSD (Britton et
al., 2005). However, in response to emotional stimuli, the mPFC demonstrates
hyperactivation coupled with hypoactivation of the ACC, representing another neural
substrate of dysregulated affect within PTSD (Garfinkel & Liberzon, 2009). Findings
regarding the ACC in individuals with PTSD indicate decreased activation in this area in
response to script driven imagery symptom provocation. Consistent across both traumatic
and non-traumatic emotional state paradigms, these results suggest that activation in this
brain region is not specific to just traumatic stimuli (Lanius et al., 2001; Lanius, Hopper
& Menon, 2003). Other studies report robust findings of decreased blood oxygenation
level dependent (BOLD) signal in the ACC in response to nontraumatic emotional
stimuli, further implicating dysregulated affect as a component of PTSD neurocircuitry
(Hsu, Chong, Yang, & Yen, 2002; Shin et al., 2001). These findings make sense
regarding dysregulated affect within PTSD, given that the ACC is believed to be
important for cognitive control of emotion and the interpretation of emotionally relevant
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stimuli (Bush, Luu, & Posner, 2000). Decreased activation in this area during a task
involving emotion regulation may represent a biomarker for the negative perception of
neutral emotional stimuli.
The insula, a vast cortical area that maintains connections with the amygdala, also
appears to be contributing to dysregulated affect within PTSD. Among the several
proposed functions of the insula, it is hypothesized to be important in the processing and
experience of affect (Wager & Barret, 2004). Individuals with PTSD tend to exhibit
increased insula activation in comparison to control subjects when presented with trauma
script related imagery (Hopper, Frewen, van der Kolk, & Lanius, 2007).
Taken together, fMRI research studies on emotion regulation within PTSD
suggest that fear circuitry alone is too simplistic to capture the complex emotional
presentation of the disorder (Diekhof, Geier, Falkai, & Gruber, 2011). Additionally, brain
regions implicated in PTSD pathology have also been found to be independently
associated with the experience of affectivity. Affective inductions typically elicit the
recruitment of the mPFC (Beauregard et al., 2001, 2004; Levesque et al., 2003; Kalisch et
al., 2005; Matsumoto et al., 2006), the ACC (Ochsner, Bunge, Gross, & Gabrieli, 2002;
Anderson & Phelps, 2002; Schaefer et al., 2002; Pissiota et al., 2003; Whittle, Allen,
Lubman & Yucel, 2006; Banks, Eddy, Angstadt, Nathan, & Phan, 2007), the amygdala
(Barrett, Bliss-Moreau, Duncan, Rauch, & Wright, 2007; Cremers et al., 2009), and the
insula (Wager & Barret, 2004).
Similar to fMRI studies of PTSD and emotion regulation, magnetic resonance
imaging (MRI) studies of PTSD have also identified structural abnormalities in areas
thought to be important for the processing of emotion. In participants with PTSD,
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decreased gray matter volumes have been observed in the ACC (Kasai et al., 2008;
Herringa et al., 2012), amygdala (Rogers et al., 2009), hippocampus (Karl et al., 2006;
Woon & Hedges, 2011; Zhang et al., 2012), insula (Chen et al., 2006; Kasai et al., 2008;
Herringa et al., 2012), and caudate nucleus (Herringa et al., 2012). Other structures such
as the hypothalamus (Herringa et al., 2012), thalamus, and globus pallidus have also
demonstrated decreased gray matter volumes in trauma exposed individuals (Shucard et
al., 2012). In contrast to fMRI findings, the relationship between affect dysregulation and
structural abnormalities within these areas has yet to be explored.
Affectivity and CPT
Generally speaking, cognitive and behavioral therapies require basic level
cognitive processes to be intact to facilitate treatment gains. Additionally, a considerable
amount of cognitive insight is often an important indicator of treatment effectiveness
(Beck, Baruch, Balter, Steer, & Warman, 2004; Holtforth, Castonguay, Boswell, Wilson,
et al., 2007). Elements of cognition and affect are integrally related (Duncan & Barrett,
2007; Forgas, 2008), as a mild to moderate presence of NA is posited to elicit adaptive
cognition functioning (Bless & Fiedler, 2006; Forgas, 2007). However, there is a
substantial amount of evidence suggesting that increasing amounts of NA actually disrupt
these preconditions for attention, processing, and memory, thus presenting an additional
challenge for CPT-oriented clinicians.
Attention
NA has been found to narrow the attentional field and induce distractibility
(Derryberry & Tucker, 1994; Fredrickson & Brannigan, 2005; Lazar, Kaplan, Sternberg,
& Lubow, 2012). Additional findings support this notion and suggest that NA moderates
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selective attention, restricting focus to threatening stimuli and magnifying the inhibitive
effect of salient distracters (Frischen, Eastwood, & Smilek, 2008; Vermeulen, 2010). NA
also undermines the ability of these neural control processes to accurately determine taskrelevant information from distracters in the presence of affective stimuli (Melcher, Born,
& Gruber, 2011). A continuous focus on threatening stimuli can become reinforced by
the introduction of a traumatic event, forming a resistant attentional pattern and
manifesting avoidant behavioral strategies often observed in individuals diagnosed with
PTSD. A constricted focus on specific stimuli also interferes with initial information
processing, likely manifesting several types of cognitive distortions, including filtering,
overgeneralization, and polarized thinking. Moreover, high levels of NA could
potentially disrupt a client’s ability to broaden their focus to consider beneficial cognitive
alternatives. In addition to a constrained focus, excessive NA can also influence the
detection of relevant stimuli in the current environment. For example, NA has been found
to facilitate inattention to relevant stimuli in the current context caused by excessive
worry, avoidance and rumination (Borkovec & Sharpless, 2004). These cognitive
processes are typically associated with the experience of NA and notoriously deplete
available cognitive resources (Derakshan & Eyesenck, 1998). Disengaging a client from
these ingrained processes may be quite challenging through the utilization of cognitive
techniques, considering the client’s already exhausted cognitive system.
Cognitive Processing
Individuals with high trait NA also tend to adopt an analytical cognitive style
when processing information (Bless & Schwarz, 1999; Vermeulen, Corneille, & Luminet,
2007). Fiedler’s affect-cognition model (2001) suggests an association between NA and
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an accommodative processing style, a rigid approach that typically preserves the initial
interpretation of novel information. Cognitive models of PTSD often recognize
overaccommodated thoughts as problematic (Sobel, Resick, & Rabalais, 2009), which
can lead to perseveration. Combined with an attenuated focus, it is understandable how a
systematic processing approach to overaccomodated cognitions might exacerbate
rumination and increase the probability of cognitive distortions. The introduction of
analytical cognitive skills to clients with high NA may appear redundant and invalidate
their emotional experience further, given their pre-existing hyperfocus on their own
thoughts. Ignored by excessive analysis, the unprocessed affect is likely to persist as a
significant contributor to emotional distress.
Memory
Higher levels of NA enhance the recall ability of autobiographical memory
(Forgas, 2010). However, the recall of such memories often exhibits emotional
congruence. As such, high NA individuals tend to retrieve significantly more emotional
memories with a negative valence than individuals low in NA (MacLeod & Campbell,
1992). Considering counterfactuals about past situations may be consistently difficult for
these clients, as the negative aspects of a situation are more easily recalled per the
availability heuristic. Individuals reporting higher levels of NA also tend to report
increased rumination regarding recalled autobiographical memories (Kross, Davidson,
Weber, & Ochsner, 2009). Thus, high NA individuals diagnosed with PTSD may tend to
dwell extensively on their history of traumatic events, further exacerbating
symptomatology and subjective distress. Giving an appropriate amount of consideration
to the positive aspects of a situation may be particularly challenging for these clients
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during CPT. NA also appears to tax working memory. Prior research has demonstrated
that individuals high in NA possess less cognitive resources to complete a primary
working memory task (Derakshan & Eyesenck, 1998; Richards, French, Keogh, &
Carter, 2000). There have been mixed results regarding the relationship between NA and
short-term memory, from which no definitive conclusions can be drawn (Shackman,
Sarinopoulos, Maxwell, Pizzagalli, Davidson, & Lavric, 2006).
Interpretation
Higher order cognitive processes, like interpretation, judgment, executive
decision-making, and reasoning are also subjected to the influence of NA (Blanchette &
Richards, 2010). Individuals high in NA tend to interpret ambiguous or neutral stimuli as
threatening and view themselves at greater risk for negative occurrences (Stopa & Clark,
2000; Huppert, Pasupuleti, Foa, & Mathews, 2007). This type of interpretative bias can
be compounded by the experience of a traumatic event, which may explain the
manifestation of certain types of PTSD symptoms, like sustained irritability, constant
surveillance of the environment, increased sensitivity to stimuli, and excessive
physiological arousal. NA also interferes with an individual’s ability to formulate
accurate judgments about ambiguous future events. Individuals high in NA tend to
overestimate the likelihood of negative events in comparison to control subjects, and
these results cannot be simply attributed to semantic priming (Constans, 2001; Forgas,
2006). This probability overestimation is problematic after the occurrence of a traumatic
event, and may fuel resistance in CPT to discounting the possibility that such an event
could ever happen again. Moreover, this increased personal experience of negative events
certainly undermines examination of “realistic” probability. Individuals high in NA also
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exhibit the propensity to engage in emotional reasoning which is often the basis of their
judgments (Clore & Huntsinger, 2007). As noted by Blanchette & Richards (2010),
pervasive NA likely results in deviations from accurate, realistic judgments.
Decision-making
Decision-making is similarly impacted by the experience of NA. Research on this
topic has traditionally been conducted using paradigms where subjects choose between
options that differ in risk and consequence. Individuals high in NA have been found to
avoid aversive options in comparison to individuals low in NA (Maner & Gerend, 2007;
Vastfjall, Peters, & Slovic, 2008). Since the potential exists for their already heightened
NA to increase as a result of a risky decision, these individuals are likely to avoid such
scenarios. Thus, a therapy client may decide that the potential evocation of state NA
through exposure is undesirable and dangerous. The decision to avoid aversive options by
high NA individuals may directly contribute to the avoidant symptom cluster in the
presence of PTSD.
Reasoning
In addition to decision-making, deductive reasoning is also inhibited by persistent
NA. A study of verbal reasoning concluded that high NA individuals exhibited more
impairments of logic than individuals with low NA. The differences between these two
groups were further exacerbated when task demands were increased (Derakshan &
Eyesenck, 1998). As negative emotionality appears to disrupt rational thought, emotional
reasoning (i.e., forming judgments based on feelings) should not be discounted
altogether. Recent findings suggest that victims of sexual abuse exhibit advantages in
reasoning regarding abuse-related content (Blanchette & Richards, 2010). Thus,
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emotional reasoning demonstrates applicability in certain trauma-related contexts, despite
being labeled as a cognitive distortion variant by CPT.
Cognitive Regulation of Emotion
The impact of NA on the cognitive regulation of emotion is a legitimate barrier to
the application of CPT principles and may be amplified in individuals with PTSD.
Indeed, NA has exhibited an inhibitive influence over cognitive control in response to
affective priming using threat-related stimuli (Blair et al., 2007; Melcher et al., 2011;
Melcher, Obst, Mann, Paulus, & Gruber, 2012). Other research demonstrates that NA
promotes cognitive inhibition, particularly in the presence of emotionally loaded
conditions like sadness (Ramon, Geva, & Goldstein, 2011). The cognitive inhibition
resulting from elevations in NA further limits the self-regulation of emotions (Magno,
2010; Bradley et al., 2011). It had been previously thought that individual differences in
affect may lead to different strategies of cognitive control, with the adoption of a reactive
control strategy in the presence of chronic NA (Braver et al., 2007). However, an EEG
study of brain activity during a neurocognitive task that assessed proactive and reactive
cognitive control revealed that trait NA weakened both types of strategies (West, Choi, &
Travers, 2010). Elevated levels of NA have also been found to interfere with performance
on executive control tasks (Moritz et al., 2002). Cognitive control is an important
component of CPT as clients are expected to react to intrusions of negative thoughts by
simultaneously accessing realistic alternative cognitions. A failure to account for
individual differences in NA may result in an unexpected attenuation of cognitive
control, leaving a client frustrated when attempting to continuously respond to negative,
self-critical cognitions.
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With the consideration of the numerous elements of cognition disrupted by NA, it
is not surprising that a greater frequency of cognitive errors is often associated with
higher levels of NA (Fetterman & Robinson, 2011). Impairments in cognition resulting
from affect dysregulation cannot simply be rectified by the rigid application of cognitive
and behavioral techniques. As clients may already be experiencing doubts about their
ability to effectively evaluate a situation or their own emotional experience, these
strategies may be perceived as initially threatening and subsequently frustrating to clients
with persistent NA. This has yet to be investigated in CPT for PTSD, however, leaving
room for speculation. Evidence consistent with this notion demonstrates that individuals
high in NA tend to be more introspective and dwell upon and magnify mistakes,
frustrations, disappointments, and threats (Glaser et al., 2006). Cognitive impairments
from NA could be complicated further in the presence of PTSD, as preexisting belief
structures are often drastically altered by the experience of a traumatic event. Routine
cognitive errors are likely to reinforce negative alterations in cognition caused by the
traumatic event, including self-critical ruminations about control and self-efficacy.
Moreover, further inhibition of higher order cognitive processes that typically regulate
negative emotions is likely to increase the salience of emotional distress in client
experiences. Clients with elevated NA ultimately need a way to regulate this distress to
subsequently engage in effective cognitive restructuring or exposure techniques.
Although adults are assumed to have developed emotion regulation skills as a
product of aging and emotional maturity (Linehan, 1993), the intense emotions associated
with a traumatic event can disrupt this development, especially if the trauma occurs at an
early age. Affect regulation skills are often among the first skills taught to children who
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have experienced a traumatic event, and these skills are automatically introduced prior to
the use of cognitive restructuring or exposure techniques. The rationale for focusing on
affect regulation, as noted by Cohen, Mannarino, & Deblinger (2006), is that the
experience of trauma often coincides with the experience of painful negative emotions.
More often than not, these children fear that they will be overwhelmed by this emotional
experience, which directly influences avoidance. Affective expression and modulation
grants these children the ability to cope with these painful emotions without resorting to
avoidant strategies. Thus, this treatment model recognizes that affect dysregulation
represents a risk factor for the development of PTSD in the presence of a traumatic
experience and serves to maintain PTSD symptomatology. Over time, it can be assumed
that a portion of these children will develop healthy emotion regulation techniques that
act as a protective factor or cause their symptomatology to remit. Though, those who
never develop those skills may become adults who continue to struggle with complex
PTSD or possibly, chronic personality disorders associated with trauma. Granted, not all
cases of PTSD begin during childhood and adolescence. However, NA still acts as a risk
and maintenance factor for PTSD in adults. So, it can be assumed that not all adults who
have not experienced a traumatic event possess the capacity to efficiently cope with
dysregulated affect if a trauma occurs. It is more likely that some adult clients will
possess the same fear of painful emotions resulting from a traumatic experience, leading
to subsequent avoidance. This makes sense, as NA is negatively associated with an
individual’s tendency to confront psychological stimuli and analyze their own thoughts,
feelings, and behaviors (Tull et al., 2007). Proceeding with CPT after considering the
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presence or absence of affect regulation skills may provide more favorable treatment
outcomes in adults with PTSD.
The Current Study
Published results from randomized controlled trials (RCT) of CPT generally
demonstrate high rates of treatment completion amongst interpersonal trauma survivors
(Nishith, Resick, & Griffin, 2002; Resick, Nishith, et al., 2002). The experience of
interpersonal trauma (i.e., traumatic event in which an individual is assaulted or violated
by another person that may be known or unknown to the trauma survivor) can manifest a
myriad of emotions other than fear including guilt, sadness, shame, disgust, and anger
(Lily & Valdez, 2012), component emotions of NA. Survivors of interpersonal trauma
tend to experience more emotion dysregulation in comparison to survivors of other types
of trauma (Ehring & Quack, 2010). It remains unknown if CPT principles sufficiently
address psychological and neurobiological dimensions of affectivity in survivors of
interpersonal trauma diagnosed with PTSD. Additionally, the question of whether
affectivity impacts the application of CPT in this population has yet to be explored.
While benefits of an affective module have been demonstrated within a CPT protocol for
a small group of survivors of child sexual abuse (House, 2006), the conclusions that can
be drawn from these findings about the need for an affective module in the larger
population of interpersonal trauma survivors are limited. This study attempts to delineate
the relationships between self-reported affectivity, neurobiological dimensions related to
affect, and CPT treatment completion.
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Hypotheses:
The current study examined the relationship between affectivity and CPT,
utilizing neuroimaging methodologies to assess affect regulation within interpersonal
trauma survivors recruited from a community setting. Neuroimaging methodologies have
demonstrated promise as an observational strategy to gauge affect regulation in research
settings (Diekhof, Geier, Falkai, & Gruber, 2011).
1)

PA and NA will be significant clinical predictors of treatment
completion, such that high NA and low PA will be associated with
subjects that dropout from CPT.

2)

Gray matter volumes in regions of interest (ROI) associated with affect
regulation will be significantly different between the treatment
completion and treatment dropout group. Participants who dropped out
of treatment are expected to have reduced gray matter volumes in
comparison to the treatment completion group. These regions include
the amygdala, ACC, prefrontal cortex, insula, and hippocampus (Figure
2).

3)

A correlational analysis will be performed to assess the relationship
between self-reported affectivity and the volumes of ROIs. NA is
expected to exhibit an inverse relationship with gray matter volumes,
such that higher scores of NA predict reduced gray matter volumes. PA
is expected to exhibit a positive relationship with gray matter volumes,
such that lower scores of PA predict reduced gray matter volumes.
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4)

Self-reported affectivity will significantly change across CPT. PA is
hypothesized to increase and NA is hypothesized to decrease.
Exploratory analyses will also be conducted within the treatment
completion group to examine the potential effects of NA and PA on
other treatment variables influenced by CPT.

5)

Brain activation in the aforementioned ROIs associated with affect
regulation has been shown to normalize across CPT treatment (Bruce et
al., in preparation). A multiple regression analysis will be performed to
assess the influence of self-reported affectivity on such changes during
the presentation of fearful faces within a task of implicit emotional
conflict.
Method

Participants
The intent-to-treat (ITT) sample was comprised of 38 women, ages 18-55 (M =
30.8 years, SD =9.2 years), recruited at the Center for Trauma Recovery (CTR), a multidisciplinary center at the University of Missouri-St. Louis, and Washington University of
St. Louis. The ITT sample was relatively diverse, with 60.5% of the participants
identifying as Caucasian, 23.7% as African American, 2.6% as Hispanic, and 5.2%
identifying as “Other.” Race was not identified for three (7.9%) participants. The sample
completed, on average, 15.3 years (SD = 2.2 years) of education. Of the women included
in this sample, 24 (63.1%) completed the full Cognitive Processing Therapy (CPT)
protocol, 9 (23.7%) received partial treatment but terminated therapy prior to completion,
and 5 (13.2%) never returned for the first session of therapy after the initial assessment.
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Participants who dropped out of treatment completed an average of 3.78 sessions (SD =
2.49), with a range of 2 sessions to 8 sessions. The modal average was 2 sessions, with 5
of 9 participants dropping out after completing session 2, which happens to be the review
of the impact statement in CPT.
Participants were included in the ITT group if they experienced an interpersonal
trauma (i.e., physical or sexual assault, molestation, or intimate partner violence) in
childhood or adulthood and met the Diagnostic and Statistical Manual of Mental
Disorders (4th ed.; DSM-IV; American Psychiatric Association, 1994) criteria for
Posttraumatic Stress Disorder (PTSD) at the time of the initial assessment, with the
interpersonal trauma reported as their criterion A event. All participants were at least one
month post-trauma of their most recent traumatic event. Other comorbid conditions were
permitted for this study as long at PTSD was the primary diagnosis. Approximately
44.7% (N = 17) of the ITT sample was diagnosed with at least one current comorbid Axis
I condition, with 21.1% (N = 8) of the sample reporting multiple comorbid conditions.
With regard to commonly reported comorbidities in the ITT group, 23.7% (N = 9)
reported comorbid depression, 23.7% (N = 9) reported comorbid specific phobia, 15.8%
(N = 6) reported comorbid social phobia, 10.5% (N = 4) reported comorbid panic
disorder, 5.3% (N = 2) reported comorbid agoraphobia without a history of panic, and
5.3% (N = 2) reported comorbid obsessive-compulsive disorder.
Baseline data from the ITT sample was compared to that of a sample of healthy
controls. The control sample was comprised of 15 women, ages 18-55 (M = 33.4 years,
SD =11.4 years), recruited at the same locations as the ITT sample. Approximately
86.7% of participants identified as Caucasian, and the remaining 13.3% identified as
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African American. The control sample completed, on average, 17.3 years (SD = 3.1
years) of education. Regarding demographic variables, age was not significantly different
(F(1, 50) = 0.75, p = .39, partial η2 = .02) between the ITT and control groups. A chisquared analysis also indicated that race was not significantly different (Χ2 (3, n = 50) =
2.66, p = .45) between the two groups. However, there was a significant difference in
years of education (F(1, 47) = 6.19, p < .05, partial η2 = .12). On average, the control
group had completed more years of education than the ITT group.
Exclusion criteria for the study included illiteracy, the inability to give informed
consent or speak English, active suicidality, Axis II conditions, current alcohol or
substance abuse disorder, schizophrenia or other psychotic disorder, bipolar disorder,
current use of psychotropic prescription or nonprescription drugs or herbals (e.g.
hypericum), primary neurological disorders, and MRI contraindications (e.g., foreign
metallic implants, pacemaker). In addition, participants were excluded from the sample if
they were involved in a currently abusive relationship or being stalked. Sample
characteristics are presented in Table 1.
Measures
Clinician-Administered PTSD Scale (CAPS; Blake, 1995)
The CAPS is a clinician-administered, 30-item scale that assesses validity,
severity, and improvement of PTSD symptoms as identified by the DSM-IV-TR over a
time period of interest (e.g., past week, past month, lifetime). These symptoms are
classified into three groups: re-experiencing (Criterion B), avoidance/numbing (Criterion
C), and arousal (Criterion D). The 1-month and lifetime time periods for each individual
symptom were assessed in the current study. The CAPS also contains separate 5-point
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frequency and intensity rating scales (0-4) for each symptom. The CAPS has
demonstrated high internal consistency (α’s = .92 - .99; Blake, 1995) and is an accepted,
valid measure of PTSD symptoms and diagnosis. Internal consistency for the CAPS was
high in the current sample (α = .87).
Structured Clinical Interview for DSM-IV-Patient Version (SCID-IV-P; First, 1997)
The SCID-IV-P is a semi-structured diagnostic interview that is administered in
both clinical and research settings. The interview is designed to assess all primary Axis I
disorders and is often used as an essential diagnostic tool. In this study, the SCID
assessed the presence of Axis I comorbidity with PTSD. Additionally, the psychotic
screen of the SCID was used for participant selection and exclusion. Symptoms are rated
using a categorical system derived from the diagnostic criterion of disorders as outlined
by the DSM-IV-TR. The SCID possesses fair diagnostic reliability (κ = 0.61-0.83)
(Lobbestael, Leurgans, & Arntz, 2011).
Positive and Negative Affect Schedule-Expanded Form (PANAS-X; Watson & Clark,
1994)
The PANAS-X, a 60-item self-report questionnaire, measures the two
predominant dimensions of self-reported mood, PA and NA. Individual items are rated on
a scale from 1 to 5, with higher scores indicating a greater extent of experiencing a
particular feeling or emotion. Respondents are instructed to reference “the past few
weeks” when endorsing items to identify consistent affective experiences. The PANAS-X
displays excellent convergent and discriminant validity and exhibits high internal
consistency (Cronbach’s coefficient alpha) for both the PA subscale (α = .83-.90) and the
NA subscale (α = .85-.90). High internal consistency was observed for both the NA (α =
.86) and PA (α = .83) subscales in the current sample.
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Posttraumatic Stress Diagnostic Scale (PDS; Foa, 1995; Foa, Cashman, Jaycox, & Perry,
1997)
The PDS is a brief screening and diagnostic instrument that assesses trauma
history and the presence and severity of PTSD symptoms based on the DSM-IV-TR
criteria. It is a clinically-oriented, 17-item self-report instrument designed for brief
administration and scoring. The frequency of each symptom is rated on a scale of 0 to 3,
with higher scores indicating a greater frequency of symptoms. The PDS is appropriate
for a wide variety of traumatic events and demonstrates high internal consistency
(Cronbach’s coefficient alpha= .92) and test-retest reliability (kappa= .74 for PTSD
diagnosis; kappa= .83 for total PDS score). Internal consistency for total PDS score was
high in the current sample (α = .88).
Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996)
The BDI-II is a self-report measure designed to assess the subjective experience
of current depressive symptoms. It contains 21 items that assess symptoms consistent
with the DSM-IV diagnostic conceptualization of MDD. Each individual item is rated on
a scale of 0 to 3, with higher scores indicating greater perceived severity of symptoms.
The BDI-II has demonstrated robust reliability and validity in diverse outpatient samples
(Cronbach’s coefficient alpha= .91) (Beck et al., 1996). Internal consistency for the total
BDI score was high in the current sample (α = .90).
Length of Battery
The length of the baseline assessment was approximately 150 to 180 minutes
depending on the participant’s trauma history and extent of Axis I psychopathology, with
an additional 90 minutes to complete the neuroimaging assessment. The length of the
final assessment battery was approximately 60 to 90 minutes, as lifetime trauma history
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and psychopathology were already assessed. The final neuroimaging assessment was,
again, approximately 90 minutes in length as the protocol is identical to that of the
baseline scan.
Training and Reliability of Interviewers
Interviews were conducted by trained, experienced clinical graduate students.
Interviewers remained in frequent contact with the Principal Investigators, Dr. Yvette
Sheline and Dr. Steven Bruce, to maintain uniform assessment criteria and to resolve
diagnostic and other rating issues. Interviewers typically met weekly with the Principal
Investigators to review any new assessments conducted to maximize reliability. Data
underwent a thorough clerical editing process before keyed into the database.
To achieve and maintain calibration among interviewers, all interviews were
audiotaped. Audiotapes were randomly selected every 2 months and coded by
independent reviewers. For each interviewer, the median reliability from the internal
consistency coefficients for all possible pairs of interviews was calculated, allowing the
identification of discordant interviewer ratings. All interviewer reliability analyses were
above 0.80, the minimum reliability threshold established for quality control at the
beginning of the study.
Image Acquisition
Cognitive fMRI studies generally yield blood oxygenated level-dependent
(BOLD) responses that are small in magnitude and distributed across the brain. The
change in BOLD signal as a result of affective inductions may be small in magnitude as
well, presenting an additional technical challenge. To detect these small changes, fMRI
methods optimized for high sensitivity to the BOLD fMRI signal with contiguous whole
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brain coverage were utilized. These methods included the use of optimized voxel sizes
and a custom echo planar imaging (EPI) pulse sequence that has approximately 20%
higher signal-noise-ratio (SNR) than the vendor pulse sequence at equivalent acquisition
settings.
All scanning was performed on the 3.0 T Siemens TRIO system at the Research
Imaging Center of the Mallinckrodt Institute of Radiology at the Washington University
Medical School. Each scanning session included acquisition of structural and functional
data. Structural imaging was used for definitive atlas registration. A 3D T2-weighted
turbo spin echo (TSE) variable flip angle (VFL) structural image was also used in the
fMRI atlas registration procedure.
Functional Magnetic Resonance Imaging (fMRI)
The functional images were collected in runs using an asymmetric spin-echo
sequence (TE = 27ms, FOV = 384 mm, flip angle = 90o) sensitive to BOLD contrast (T2*
weighting). Thirty-six contiguous, 4.0 mm thick slices were acquired parallel to the
anterior-posterior commissure plane (4.0 mm approximately isotropic voxels) providing
complete brain coverage. Each fMRI run included 180 volumes continuously acquired at
a repetition time (TR) of 2.2 seconds.
Statistical Parametric Mapping software, version 12 (SPM12; Wellcome
Department of Cognitive Neurology, London, UK) was used to prepare functional images
for analysis. To account for head motion, images were aligned to a subject-specific mean
fMRI image. Images were then slice time corrected to account for interslice temporal
differences. Next, the coregistration of each subject’s structural and functional image was
performed. The coregistered structural images were segmented into gray matter, white
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matter, cerebrospinal fluid, bone, soft tissue, and air/background using the New Segment
tool for SPM12 (Ashburner & Friston, 2005). MRI data was then normalized to standard
Montreal Neurological Institute (MNI) space utilizing deformation fields. Normalized
images were filtered with an 8mm full width at half maximum (FWHM) Gaussian kernel.
Movement outliers were identified using the Artifact Detection Tool (ART; WhitfieldGabrieli, 2011) software package. ROIs were specified a priori based on previous
literature regarding the neurobiological correlates of affectivity and emotion regulation in
PTSD (Figure 2). The Wake Forest University PickAtlas toolbox for SPM12 was utilized
to define these regions as specified by Tzourio-Mazoyer and colleagues (2002).
PsyScope Presentation
During the neuroimaging assessment, affective inductions were presented using
PsyScope on an iMac Macintosh computer. The images were projected onto a computer
screen behind the subject’s head within the imaging chamber. The screen was viewed
using a mirror attached to the head coil positioned directly above the subject’s face. A
fiber-optic, light-sensitive key press interfaced with the PsyScope button box was utilized
to record the subject’s behavioral performance during the task.
Conflict Task Description
The conflict task involved implicit emotional conflict which can be used to
examine emotional dysregulation experienced by participants in response to emotional
stimuli. Prior to the conflict task, there was a 30 second period during which the
participant fixated their vision on a crosshair. After the fixation period, the affective
inductions were presented. The affective inductions were comprised of stimuli that
display four pictures, with two faces and two houses arranged in vertical and horizontal
pairs. All pictures were black and white photographs presented on a gray background
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through a mirror taken from Paul Ekman’s series adapted by D. Perrett, courtesy of John
Morris and colleagues. The task required the subject to match either faces or houses in
which flanking distracters were either faces or houses (Fales et al., 2008). Ten faces
displaying negative emotion, ten neutral faces, and 20 houses unfamiliar to the subjects
were used. In different sequences of trials, subjects were instructed to attend to either just
the horizontal or just the vertical pair of stimuli. Subjects then indicated whether these
stimuli were the same or different by pressing corresponding buttons with the right hand
while ignoring the other stimulus pair. All four sequences included 52 trials for a total of
208 events. Following the conflict task was another 30 seconds of crosshair fixation. Two
conditions within the conflict task were of particular interest in relation to the
manifestation of PTSD following an interpersonal trauma: the attention to fearful faces
(AF) and the ignoring of fearful faces (IF). Two comparison conditions were also
produced by the task: the attention to neutral faces (AN) and the ignoring of neutral faces
(IN)
Structural Magnetic Resonance Imaging
Structural MRI scans were collected from all participants during the baseline
assessment. The structural images were acquired with 1x1x1 voxel resolution using a
sagittal 3-D MPRAGE sequence (TE = 3.13 ms, FOV = 256 mm, flip angle = 8o, TI =
1000 ms) with T1-weighting. Each high-resolution structural image included 176 slices
continuously acquired at a repetition time (TR) of 2.4 seconds.
Voxel-Based Morphometry version 8 (VBM8) toolbox (http://dbm.neuro.uni--‐
jena.de/vbm8/) within SPM12 was used to prepare structural images for analysis. Once
acquired, structural images were aligned to a subject-specific mean MRI image. Images
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were then normalized to a template space and segmented into gray matter, white matter,
and cerebrospinal fluid. A quality check was then conducted to ensure the accuracy of the
segmentation and normalization procedures. Normalized images were filtered with a
12mm full width at half maximum (FWHM) Gaussian kernel. Similar to the functional
analysis, ROIs included the amygdala, ACC, prefrontal cortex, insula and hippocampus.
The Wake Forest University PickAtlas toolbox for SPM12 was utilized to define these
regions as specified by Tzourio-Mazoyer and colleagues (2002).
Therapists and Treatment Overview
Therapists included four women and three men with master’s degrees or
doctorates in clinical psychology. All therapists were trained in the administration of
cognitive behavioral therapy. The assignment of clients was balanced so that therapist
caseloads would be relatively equal throughout the study. All therapy sessions were
videotaped for review by the primary investigator. Monitoring of individual cases
occurred at weekly group supervision sessions attended by all therapists and directed by
the primary investigator.
After completion of the initial assessment, all participants were immediately
assigned to a therapist for CPT. While some of the therapists also acted as interviewers
for the study, participants were assigned to a separate individual for the treatment phase
to eliminate assessor bias. Once participants completed treatment, they were, once again,
evaluated by an independent assessor. Therapy consisted of 12 weekly sessions, each 60
minutes in length. Treatment was scheduled to be completed within 12 weeks, but
additional sessions were allowed if needed to complete the protocol.
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CPT
CPT was administered in accordance with the manual updated to include more
coherent wording on all therapy worksheets (Resick & Schnicke, 1993; Resick, 2001).
CPT facilitates the identification and challenging of cognitive distortions embedded
within an individual’s belief structure of the self, others, and the world. The experience of
a traumatic event is believed to alter this belief structure, manifesting cognitive
distortions that maintain PTSD symptoms. CPT is delivered in a highly structured format
intended to standardize the administration of the protocol. Session 1 begins with
psychoeducation about the nature and symptoms of PTSD, rationale for CPT, and the
assignment of an impact statement which requires the client to subjectively describe the
meaning of their trauma. During the second session, clients read and discuss their impact
statement and are introduced to the connection between events, thoughts, and emotions.
Session 3 introduces the trauma narrative, an assignment which requires the client to
write a descriptive account of their traumatic experience. At the beginning of session 4,
the client reads the account to the therapist. The remainder of the session is allotted to the
identification and challenging of cognitive distortions within the account, allowing the
client to process their trauma. Socratic questioning is also used within this session to
challenge notions of self-blame. The client is asked to re-write their account with
increased detail for the following session. This account is processed in sessions 5 and 6 as
challenging and changing cognitive distortions becomes the focus of therapy. Clients are
taught to recognize their negative automatic thoughts and identify recurrent core beliefs
that manifest such thoughts.
Beginning with session 7, clients are challenged to generate balanced alternative
thoughts in response to their dysfunctional cognitions. Session homework consists of
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advanced worksheets designed to assist clients in practicing the development of these
statements. Sessions 7 through 12 address overgeneralized core beliefs about topics
including safety, trust, power/control, intimacy, and self-esteem. Clients are asked to
rewrite their impact statement at the conclusion of session 11, and this impact statement
is compared to their original statement in the final session. This exercise provides an
excellent opportunity to review treatment progress and discuss topics on which the client
might continue to work.
Procedure
During a brief telephone screen, a graduate research assistant explained the
project to all potential participants. Eligible participants were then scheduled for the
initial assessment. During the baseline assessment, informed consent was obtained, and
participants were informed that eligibility for treatment would be determined. This
assessment began with administration of the CAPS-I and the SCID-I to assess trauma
history and current and lifetime psychopathology. Participants who met eligibility
requirements were then administered a standardized trauma interview to assess variables
relevant to the traumas experienced as well as any treatment history. Participants then
completed other clinician-administered and self-report assessments. Within three days of
the initial assessment battery, participants were scheduled for the neuroimaging portion
of the study. Upon completion of the fMRI scan, participants were assigned to a therapist,
and CPT was initiated. All participants were administered the full CPT protocol before
the termination of therapy. Immediately following the completion of CPT, participants
were scheduled for their follow-up assessment and scan. The follow-up assessment
consisted of the same protocol as the baseline assessment, except that only current
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psychopathology was assessed. The follow-up scan protocol was identical to the baseline
scan, as both scans included the affective induction and the collection of structural and
functional images. Data collection occurred between September 2009 and August 2013.
Results
Pre-treatment Clinical Variables
A one-way between-subjects ANOVA compared the mean scores of clinical
variables (i.e., BDI, PDS, PA, NA) between the ITT group and healthy control group. All
comparisons of clinical variables were statistically significant. BDI scores (F(1, 46) =
32.13, p < .001, partial η2 = .41) were greater in the ITT group (M = 24.26, SD = 11.00)
than in healthy controls (M = 4.20, SD = 3.16). PDS scores (F(1, 46) = 60.75, p < .001,
partial η2 = .57) were also greater in the ITT group (M = 28.44, SD = 10.34) than in
healthy controls (M = 3.92, SD = 5.70). Additionally, NA scores (F(1, 51) = 35.73, p <
.001, partial η2 = .41) were greater in the ITT group (M = 28.84, SD = 8.63) in
comparison to healthy controls (M = 14.93, SD = 3.94). As expected, PA scores (F(1, 51)
= 40.12, p < .001, partial η2 = .44) were significantly lower in the ITT group (M = 23.68,
SD = 7.51) than in healthy controls (M = 37.87, SD = 6.90).
Similarly, a series of one-way between-subjects ANOVAs were conducted to
compare the mean scores of clinical variables (i.e., BDI, PDS, PA, NA) at pre-treatment
between the treatment completion and treatment dropout groups. These analyses
specifically tested the hypothesis that NA scores would be higher and PA scores would
be lower in the treatment dropout group versus the treatment completion group. Results
only partially supported this hypothesis as NA scores (F(1, 36) = 0.06, p = .812, partial η2
= .002) were not significantly different between the treatment completion group (M =
28.58, SD = 8.90) and treatment dropout group (M = 29.29, SD = 8.43). However, PA
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scores (F(1, 36) = 5.29, p < .05, partial η2 = .13) were significantly different between the
groups, such that the treatment dropout group had lower scores (M = 20.21, SD = 6.07)
than the treatment completion group (M = 25.71, SD = 7.63). BDI scores (F(1, 36) =
7.02, p < .05, partial η2 = .16) were greater in the treatment dropout group (M = 30.00,
SD = 9.73) than in the treatment completion group (M = 20.92, SD = 10.45). PDS scores
(F(1, 34) = 9.26, p < .01, partial η2 = .21) were also greater in the treatment dropout
group (M = 34.36, SD = 8.12) than in treatment completers (M = 24.68, SD = 9.96). This
observed difference in PDS scores, a self-report measure, was inconsistent with results
from the CAPS, a clinician-administered measure, as CAPS scores (F(1, 36) = 2.29, p =
.14, partial η2 = .06) were not significantly different between the treatment dropout group
(M = 77.43, SD = 15.34) and the treatment completion group (M = 67.96, SD = 20.21).
To further understand the differences between individuals who initially present
for treatment, one-way between-subjects ANOVAs were utilized to examine the
differences on clinical variables of interest between the treatment completion group, a
treatment dropout group comprised of individuals who presented for at least one session
of CPT, and a treatment dropout group comprised of individuals who expressed interest
in treatment but never attended any sessions of CPT. NA scores were not significantly
different (F(2, 35) = 0.07, p = .93, partial η2 = .04) between the groups. PA scores,
interestingly, were trending towards significance across the groups (F(2, 35) = 2.86, p =
.07, partial η2 = .14). Pair-wise comparisons (i.e., Tukey’s HSD Procedure) were then
utilized to examine this trend. While the mean difference between PA scores was not
significantly different (p = .12) between the treatment completion (M = 25.71, SD = 7.63)
and treatment dropout after attending groups (M = 21.22, SD = 6.12), the mean difference
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between PA scores was significantly different (p < .05) between the treatment completion
and dropout before attending groups (M = 18.40, SD = 6.19). The mean difference
between PA scores of the treatment dropout after attending and treatment dropout before
attending was not significant (p = .48).
With regard to specific symptom measures and presentation for treatment, BDI
scores were significantly different across the groups (F(2, 35) = 3.52, p < .05, partial η2 =
.17). Similar to self-reported PA scores, BDI scores were significantly different (p < .05)
between the treatment completion group (M = 20.92, SD = 10.45) and the dropout before
attending group (M = 31.60, SD = 5.22). Unlike the PA analysis, a significant difference
was also observed (p < .05) between the treatment completion group and the dropout
after attending group (M = 29.11, SD = 11.73). BDI scores in the dropout before
attending and after attending groups were not significantly different (p = .67). The same
trend was present in the analysis of PDS scores. PDS scores were significantly different
across the groups (F(2, 33) = 4.83, p < .05, partial η2 = .23). In pair-wise comparisons of
mean differences, PDS scores were significantly different (p < .05) between the treatment
completion group (M = 24.68, SD = 9.96) and the dropout before attending group (M =
36.80, SD = 6.30). A significant difference was also observed (p < .05) between the
treatment completion group and the dropout after attending group (M = 33.00, SD =
9.03). PDS scores in the dropout before attending and after attending groups were not
significantly different (p = .47). CAPS scores were not significantly different across the
three groups (F(2, 35) = 1.46, p = .25, partial η2 = .08). Correlations of clinical variables
assessed in the ITT sample at pre-treatment are presented in Table 2.
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Post-treatment Clinical Variables
To test the hypothesis that CPT will reduce NA and increase PA, one-way withinsubjects ANOVAs were used to compare changes in the mean scores of clinical variables
from pre-treatment to post-treatment within treatment completers. Indeed, NA scores
changed significantly across treatment (F(1, 21) = 24.32, p < .001, partial η2 = .54) such
that participants had lower scores post-treatment (M = 18.96, SD = 7.97) than at pretreatment (M = 28.55, SD = 9.19). Additionally, CPT also significantly increased PA
(F(1, 21) = 14.21, p < .01, partial η2 = .40) from pre-treatment (M = 25.91, SD = 7.12) to
post-treatment (M = 31.36, SD = 7.97). Thus, these results support the a priori hypothesis
regarding the impact of CPT on affectivity. Other clinical variables also were
significantly modified over the course of treatment. BDI scores were significantly
reduced (F(1, 22) = 46.93, p < .001, partial η2 = .68) from pre-treatment (M = 20.70, SD
= 10.63) to post-treatment (M = 9.00, SD = 8.61). PDS scores were also significantly
reduced (F(1, 18) = 40.23, p < .001, partial η2 = .69) from pre-treatment (M = 24.16, SD
= 10.18) to post-treatment (M = 10.47, SD = 10.11). Likewise, CAPS scores were
significantly reduced (F(1, 22) = 117.99, p < .001, partial η2 = .84) from pre-treatment (M
= 67.00, SD = 20.10) to post-treatment (M = 23.17, SD = 21.37). These results are
presented in Table 3. Correlations of clinical variables assessed in the ITT sample at posttreatment are presented in Table 4.
Exploratory analyses were also conducted within the treatment completion group
to examine the potential effects of pre-treatment NA and PA on other treatment variables
influenced by CPT. Dependent variables included the change scores from baseline to
post-treatment assessment in self-reported BDI scores, PDS scores, and CAPS scores.
Results indicated that baseline self-reported NA was significantly associated with
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changes in PDS scores (F (1, 26) = 5.77 p < .05, R2 adj =.15; β = .43, p < .05) and BDI
scores (F (1, 29) = 11.84 p < .01, R2 adj =.27; β = .54, p < .01). Thus, greater change
scores on the BDI and PDS were observed in participants with higher NA at pretreatment. Baseline NA was not a significant predictor of changes in CAPS scores or PA
across treatment. Baseline PA was a significantly associated with changes in PDS scores
(F (1, 26) = 7.36 p < .05, R2 adj =.22; β = -.47, p < .05), BDI scores (F (1, 29) = 8.71 p <
.01, R2 adj =.20; β = -.48, p < .01), and NA (F (1, 29) = 6.14 p < .05, R2 adj =.15; β = .42, p < .05) across CPT. As such, participants with lower PA scores at pre-treatment
experienced the greatest decreases across these clinical variables. PA was not
significantly associated with changes in CAPS scores across treatment.
Structural Magnetic Resonance Imaging
Group Analyses
To test the second hypothesis that gray matter volumes would be significantly
different between the treatment completion group and the treatment dropout group in
identified ROIs, between-group comparisons of gray matter volume were performed with
the VBM8 toolbox using the general linear model (Friston et al., 1994). Each comparison
generated two t-statistic maps that corresponded with opposing contrasts of gray matter
volume (i.e. increased and decreased volume). To correct for multiple comparisons
within identified ROIs, Monte Carlo simulations using 3dClusterSim based in AlphaSim
(Ward, 2000) were performed. As a result of 10,000 Monte Carlo simulations, Type I
error was maintained at p = .05 using a combined voxel and uncorrected significance
threshold of k = 271 and p < .005.
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Comparison of the treatment completion and treatment dropout groups using
VBM analyses indicated that gray matter volumes were not significantly different
between the groups. However, a closer look at the entire treatment dropout group yielded
significant results. When compared to the subjects that dropped out from treatment before
attending a session, the treatment group demonstrated significantly greater gray matter
volumes in the bilateral parahippocampal gyrus/entorhinal cortex (Figure 3). When
compared to the subjects that dropped out of treatment after attending at least one
session, the treatment group had significantly reduced gray matter volumes in the
bilateral supplementary motor area, left postcentral and precentral gyrus, and bilateral
calcarine (Figure 4). Group results are presented in Tables 5 and 6.
An exploratory analysis of structural gray matter differences between all PTSD
participants and healthy controls surprisingly yielded no significant differences. Given
the aforementioned significant differences in gray matter volumes between the PTSD
treatment groups, comparisons were also performed between the various treatment
groups (i.e., treatment completers, treatment dropouts, & treatment no-shows) and the
healthy control group. Results indicated that treatment completers were not significantly
different from healthy controls in terms of brain structure.
There were no significant differences in gray matter volumes between healthy
control participants and participants who dropped out of treatment prior to attending a
session as well. However, this was not the case for participants who dropped out of
treatment after participating in therapy. Participants who dropped out of treatment after
attending at least one session had increased gray matter volume in the left superior frontal
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cortex, the right precuneus, and the left calcarine (Figure 5). Results from this
comparison are presented in Table 7.
Regression Analyses
To test the third hypotheses regarding the relationships between affective
dimensions and gray matter volumes in ROIs, a series of multiple regressions were also
performed. The VBM8 toolbox subsequently generated two contrast maps corresponding
with opposing relationships between gray matter volumes and the variable of interest
(i.e., positive and negative association). Since the same ROI mask was used for the group
analysis, Type I error was maintained at p = .05 using a combined voxel and uncorrected
significance threshold of k = 271 and p < .005.
Within the PTSD treatment group, NA demonstrated a significant positive
association with gray matter volume in the right parahippocampal gyrus. These results
remained consistent after controlling for depression symptoms (i.e., BDI scores). PA was
found to be positively associated with gray matter volume in the right middle frontal
gyrus (Brodmann Area 10) and right precuneus (Figure 6). These results also remained
consistent after controlling for depression symptoms. Regression analyses were not
conducted within sub-groups of the PTSD treatment group, as an analysis of each group
(i.e., treatment completers, treatment dropout before attending, treatment dropout after
attending) would have been significantly underpowered because of their small sample
sizes, respectively.
In comparison, NA was found to have an inverse relationship with gray matter in
the bilateral superior medial frontal gyrus, bilateral middle cingulate, and bilateral medial
frontal orbital gyrus in the healthy control group. PA demonstrated a significant positive
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association with gray matter in the left postcentral gyrus in healthy controls as well
(Figure 7). Results from the regression analyses in both groups are presented in Table 8.
Functional Magnetic Resonance Imaging
In a subset of participants from the current sample, Bruce and colleagues (in
preparation) demonstrated that CPT treatment completers exhibit functional activation
patterns during the conflict task that appear more similar to that of control subjects
instead of individuals with PTSD, suggesting that CPT may normalize brain function
during this task. The final hypothesis of this project attempted to explore the relationships
between affectivity and brain activation in ROIs during the conflict task prior to the
application of CPT and how these relationships changed post-treatment. Multiple
regressions were performed between both affect variables and brain activation in ROIs
during the four main conditions of the conflict task (i.e., AF, IF, AN, IN). Similar to the
structural analyses, Monte Carlo simulations using 3dClusterSim based in AlphaSim
(Ward, 2000) were performed to correct for multiple comparisons within identified ROIs.
As a result of 10,000 Monte Carlo simulations, Type I error was maintained at p = .05
using a combined voxel of k = 116 and uncorrected significance threshold of p < .005.
Pre-treatment Results
During the AF condition at pre-treatment, significant inverse relationships were
observed between NA and activation in the left superior frontal gyrus and right calcarine,
such that as NA increases, activation in these areas decreases. During the AF condition,
PA demonstrated a significant positive association with activation in the left postcentral
gyrus (Figure 8). PA also exhibited a significant inverse relationship with activation in
the left parahippocampal gyrus during the IF condition (Figure 9) and the bilateral
parahippocampal gyrus during the IN condition (Figure 10). Further, a significant
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positive relationship between PA and activation in a large cluster in the right inferior
orbitofrontal cortex during the IN condition was observed. No significant results were
observed in the AN condition at pre-treatment. These results are presented in Table 9.
Post-treatment Results
At post-treatment, all of the significant relationships between affectivity and
activation in ROIs at pre-treatment were not significant. During the AN condition, NA
was inversely associated with activation in the right superior frontal and right middle
orbitofrontal cortices. Thus, as NA decreases, activation in these areas increases. A
significant positive relationship between PA and the left superior frontal cortex was also
observed during the AN condition (Figure 13). During the AF condition, PA was found to
be inversely related to activation in the left postcentral gyrus, right precentral gyrus, left
fusiform gyrus, and the right precuneus (Figure 11). As PA was found to significantly
increase across the course of CPT, this result implies that greater PA is associated with
reduced activation in these areas. A final analysis of the IF condition at post-treatment
yielded a significant positive relationship between PA and the right middle frontal cortex
(Figure 12). No significant results were observed in the IN condition at post-treatment.
These results are presented in Table 10.
Discussion
Clinical Variables
The current project sought to examine the interactions between affectivity, brain
structure and function, and CPT treatment outcomes in a sample of female interpersonal
trauma survivors with PTSD. Analysis of pre-treatment clinical variables indicated that
the ITT sample was highly symptomatic. In comparison to the healthy control group, the
ITT sample in this study exhibited significantly higher levels of both PTSD and
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depression symptoms. Consistent with this observation, the ITT sample also reported
significantly increased NA and reduced PA. Of the participants enrolled in CPT (N = 38),
approximately 63% (N = 24) completed treatment, 24% (N = 9) dropped out after
receiving partial treatment, and 13% (N= 5) never attended a therapy session. These rates
of CPT treatment completion mirror that of prior CPT trials in interpersonal trauma
survivors with PTSD (72%; Galovski, Blain, Chappuis, & Fletcher, 2013).
Indeed, CPT was effective in reducing PTSD-related symptoms for completers,
resulting in an average CAPS score reduction of approximately 44 points from pretreatment (M = 67.00, SD = 20.10) to post-treatment (M = 23.17, SD = 21.37). Symptoms
of self-reported depression were similarly reduced. It was initially hypothesized that CPT
would also reduce self-reported NA and increase PA. The present findings support this
hypothesis for both affective variables, as CPT resulted in large reductions (partial η2 =
.54) in NA and moderate increases (partial η2 = .40) in PA. As such, it appears that CPT
can address concerns of both general distress and difficulties in experiencing positive
emotion in a majority of treatment-seeking individuals without a module that specifically
targets either.
While CPT was useful for the majority of the PTSD sample, the treatment was
unable to address the clinically significant concerns of 14 participants. Randomized
controlled trials often explicitly focus on participants who complete treatment, and
treatment dropout issues remain unexamined. In fact, treatment dropout is frequently
explained as a function of logistical issues for clients (i.e., transportation, financial
concerns). However, there is some evidence to suggest that clinically relevant variables
like frequency of abuse experienced in childhood (Resick, Suvak, & Wells, 2014) and
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pre-treatment symptoms of depression, guilt, and anger (Rizvi, Vogt, & Resick, 2009) are
predictive of treatment completion.
With these limitations in mind, it was hypothesized that NA and PA would be
significant predictors of CPT completion and dropout. This hypothesis was only partially
supported, as pre-treatment NA was not significantly different between the treatment
completion and treatment dropout groups. Pre-treatment levels of NA were associated
with change scores across CPT in other self-report measures in the study including the
PDS and BDI, which may reflect a relationship between current distress reported across
all measures. Higher levels of NA were associated with greater changes in self-reported
PTSD and depression symptoms. NA was not associated with changes on the CAPS or in
PA.
PA was significantly different between the groups, such that participants who
dropped out of treatment had lower levels of PA at pre-treatment. Further analysis of the
dropout group yielded findings that the lowest levels of PA were observed in participants
that never attended a therapy session. Thus, reduced PA at pre-treatment may represent
an additional risk factor for CPT dropout. Similarly, the treatment dropout group also
self-reported higher levels of both PTSD and depression symptoms than the treatment
completion group. Interestingly, PTSD symptoms obtained through a clinician
administered instrument were not different between the groups, suggesting that subjective
perception of the severity of both PTSD and depression symptoms may be related to
suboptimal treatment outcomes. Similar to NA, pre-treatment PA was also predictive of
change across CPT on the PDS and BDI. PA was not associated with change in CAPS
total score. Interestingly, PA was predictive of change in NA across treatment. Lower PA
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was indicative of greater reductions in NA for participants who were retained in
treatment. This finding suggests that the capacity to increase PA may be an effective
means of reducing NA; but reducing NA may not necessarily result in increased PA.
The insignificant finding between NA and treatment dropout is surprising, given
the literature that identifies a relationship between self-reported NA and PTSD symptom
severity (Brown et al., 2014). While symptom severity seems to be associated with
treatment completion in this sample, the experience of increased NA is a non-factor.
While this finding may simply be a result of insufficient power to detect small differences
related to the size of the current sample, it does have implications for the application of
CPT in interpersonal survivors, especially with consideration of the positive finding for
PA between the groups. Currently, there some evidence to suggest that the augmentation
of CPT (House, 2006) with affect regulation modules to address heightened, dysregulated
affect enhances treatment effectiveness. The initial application of such modules was an
extension of the hypothesis that individuals with high levels of NA may be unwilling or
unable to tolerate the brief exacerbations of negative emotion that often accompany
exposure techniques. However, it may only be necessary to apply these modules to
certain populations with affect regulation concerns, as affect regulation modules have
only demonstrated effectiveness in survivors of childhood sexual abuse with PTSD
(House, 2006; Wolfsdorf & Zlotnick, 2001). These modules have yet to be examined
with other variants of trauma in conjunction with objective measures of affectivity. While
the present sample did include participants with childhood sexual trauma, events
experienced as interpersonal traumas were highly variable across participants. Future
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directions of the current project include an analysis of self-reported affect by trauma type
and subsequent treatment outcome.
The significant difference in PA between the treatment completion and treatment
dropout group is intriguing, given inconsistent findings regarding the relationship
between PA and PTSD symptoms. For example, Brown and colleagues (2014) observed
that PA was not a predictor of PTSD symptom severity or individual PTSD symptom
cluster scores in a group of female interpersonal trauma survivors with PTSD. This study
was only one of few to examine PA within the context of PTSD, as PA was traditionally
conceptualized as primary latent construct of depression. However, a comparative study
found that PA accounted for a significant amount of variance amongst both PTSD total
symptom severity and numbing symptoms, although NA was the most significant
predictor in these models (Fetzner et al., 2012). It is important to recognize that previous
research on the relationship between PA and PTSD symptoms was conducted within the
context of the DSM-IV-TR conceptualization of PTSD, not the DSM-5 conceptualization
that includes a new symptom cluster addressing changes in affect and cognition as
posttraumatic sequelae. While results of the current analyses cannot determine the extent
to which PA is related to PTSD symptoms, the observed findings are consistent with
previous research linking lower levels of PA with greater symptoms of depression in
individuals with PTSD (Post et al., 2011). Additionally, these results suggest that low
levels of PA may represent a broad risk factor for treatment dropout regardless of the
relationship with PTSD symptoms, particularly during the initial stages of a manualized
treatment protocol that may not specifically address the enhancement of PA.
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Furthermore, prior research suggests that PA may be much more than a latent
construct of depression that warrants attention within the treatment of all emotional
disorders. In fact, Brown and colleagues (1998) suggest that low PA may be feature and
general diathesis of both mood and anxiety disorders after identifying a significant
relationship between PA and social anxiety. Moreover, this relationship was similar in
strength to the observed relationship in the same sample between PA and depression after
accounting for variance in NA. Consistent with these findings, the current results suggest
that more research is needed to determine the role of low PA in the conceptualization of
emotional disorders, including PTSD.
The findings of the current study create a new dialogue in the application of
manualized treatments for PTSD: what is the role of PA in client dropout amongst other
viable explanations, including the common attribution to client logistical issues like
financial or transportation concerns? The usefulness of this dialogue will not be found in
efforts to determine which risk factor is most important but in the acknowledgement that
addressing clinical variables such as low levels of PA or high levels of depression
symptoms may indeed alter treatment completion trajectories. However, this recognition
comes at the cost of scrutinizing the weaknesses of manualized protocols instead of
dismissing treatment dropout as a product of individual client factors that cannot be
addressed in therapy. Alterations to treatment plans including manualized protocols for
individual clients that exhibit clinical indicators of dropout may indeed reduce treatment
attrition rates. This is especially salient for empirically-based approaches for PTSD, like
CPT and PE, which require clients to endure possible temporal increases in distress at the
outset of therapy related to exposure techniques. Possible solutions include augmenting
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current PTSD protocols with treatment components aimed at increasing PA, such as
Behavioral Activation (BA; Jacobson et al., 1996), or creating and utilizing integrated
protocols, such as Behavioral Activation and Therapeutic Exposure (BA-TE; Gros et al.,
2012).
Structural Results
Within PTSD Treatment Group
The second hypothesis of this project proposed that gray matter reductions in
ROIs theoretically linked with PTSD would be observed in the treatment dropout groups
versus the treatment completion group. The results only partially supported this
hypothesis, as gray matter volumes of the amygdala, insula, and ACC were not
significantly different between the groups. While no significant differences were
observed between the treatment completion group and the entire treatment dropout group,
a closer look at the dropout group yielded interesting findings. Participants who never
attended a therapy session exhibited significantly reduced gray matter in the bilateral
parahippocampus and entorhinal cortex in comparison to completers. Results of the
analysis between completers and treatment dropouts who attended at least one treatment
session were also significant. Unexpectedly, treatment completers exhibited decreased
gray matter volume in the bilateral supplementary motor area, left postcentral and
precentral gyrus, and bilateral calcarine compared to those who dropped out after partial
treatment.
Prior to the interpretation of these results, the non-significant results involving
primary regions implicated in emotion regulation must be explored. The first possible
explanation is that the analysis was underpowered. The entire clinical sample included 38
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participants, comprised of 24 completers and 14 dropouts. An a priori analysis using
G*Power statistical software yielded results indicating that a sample size of 28 would be
required to detect large effects (d =1.00) between two groups at a power (1-β) of 0.80.
However, only five participants dropped out of treatment after enrollment but before
attending a session, significantly limiting the power of these secondary analyses. While
the sample size of the treatment dropout before attending group could surely be
scrutinized as a limitation, the overall sample size of participants that were both enrolled
in treatment and administered an MRI scan is impressive for a neuroimaging study. The
analysis is also worthwhile, given that little is known about the minority of individuals
with PTSD for whom CPT is ineffective. The second possible explanation is that
differences in smaller brain regions may not have met the stringent multiple comparisons
threshold for significance, given the broad scope of regions examined in the current
analysis. The ROI mask for this study included all brain areas relevant to both emotion
regulation and PTSD, thus increasing the number of theoretical comparisons. It is
possible that a more focused analysis would yield significant findings in these regions.
Nonetheless, it is worth noting that the areas identified with reduced gray matter
in treatment dropouts in this analysis (i.e., bilateral entorhinal cortex and
parahippocampal gyrus) have been implicated in theoretical models of PTSD. For
example, Sparta and colleagues (2014) found that inhibiting the projections from the
basolateral amygdala to the entorhinal cortex reduced freezing behavior in animals reexposed to a traumatic stimulus. When the pathway was not inhibited, the animals
continued to freeze in response to contextual re-exposure. The entorhinal cortex is also
thought to play a role in altered visual processing via the ventral stream of the visual
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system in individuals with PTSD, who have been found to exhibit reduced activity in the
entorhinal cortex during a picture-viewing task than trauma-exposed controls (MuellerPfeiffer et al., 2013). Reduced white matter integrity has also been reported in the
cingulum, an area that connects the entorhinal cortex to the ACC in individuals with
PTSD (Fani et al., 2012). Indeed, the entorhinal cortex may play an important role in
emotion regulation, as documented projections include the hippocampus, insula,
amygdala, and ACC (Canto, Wouterlood, & Witter, 2008). While only a paucity of
research has examined the entorhinal cortex within the context of PTSD, several studies
have observed reduced gray matter volume in the hippocampal gyrus of individuals with
PTSD versus healthy controls (see Meng et al. [2014] for a review).
In consideration of the previous literature, the present findings suggest that gray
matter volume in the entorhinal cortex and parahippocampus may not only differ between
individuals with PTSD and healthy controls but also across individuals with PTSD. This
observation is noteworthy as studies of VBM do not explicitly identify gray matter
volume as a continuous variable. Generally speaking, group comparisons unintentionally
imply dichotomous assumptions about brain volume (i.e., either reduced/increased or
not). As such, within-group explorations of volumetric variations may have important
practical implications. Results from the current project suggest that individuals with
PTSD who exhibit the greatest reductions in volumes of these areas may be at risk for
treatment dropout.
With regard to the observed results in gray matter volume between completers
and therapy dropouts after partial attendance, the treatment group exhibited significantly
reduced gray matter volumes in the bilateral supplementary motor area, left postcentral
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and precentral gyrus, and bilateral calcarine. Volumetric findings in these areas are not
surprising, given that both functional and connectivity neuroimaging studies have
identified abnormal function in these regions in participants with PTSD. For example,
one study found that flashbacks appeared to be related to activity in the precentral gyrus
and supplementary motor area during a recognition task with personally relevant stimuli
in participants with PTSD (Whalley et al., 2013). Kennis and colleagues (2015) found
reduced connectivity between the ACC and precentral gyrus in veterans with PTSD
versus healthy controls. The precentral gyrus has also been linked to physiological
arousal (e.g., heart rate) (Barkay et al., 2012) and dysfunctional information processing
(Bae, Kim, Im, & Lee, 2011) in participants with PTSD. Another relevant study found
increased activity in the precentral gyrus and decreased activity in the left fusiform gyrus
and parahippocampal gyrus in PTSD participants in comparison with healthy controls
during an fMRI paradigm sequence of videos with a positive emotional valence (Jatzko et
al., 2006). The authors of this study suggest that the findings may be related to the
experience of emotional numbness in PTSD. In summary, increased activity in the
precentral gyrus in PTSD may relate to excessive cognitive regulation and subsequent
emotional numbing (Bremner et al., 1999; Shaw et al., 2002; Jatzko et al., 2006),
hyperarousal (Barkay et al., 2012), and flashbacks (Whalley et al., 2013).
Similarly, the supplementary motor area has also been identified as salient to
PTSD in functional connectivity studies (Whalley et al., 2013; Shang et al., 2014).
Disruptions of this area are thought to be related to hyperarousal symptoms (MuellerPfeiffer et al., 2014) and disruptions of working memory (Shaw et al., 2009). Abnormal
functioning of the calcarine has been associated with the negative interpretation of neutral
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faces in patients with panic disorder (Petrowski et al., 2014), which suggests that a
similar predisposition may be present in individuals with PTSD. Disruption of the
calcarine may be particularly salient to interpersonal trauma survivors, given that other
people can become feared stimuli depending on the nature of the experienced traumatic
event (e.g., interpersonal trauma survivor fears all men following a sexual assault
perpetrated by a man). There is a paucity of published functional findings regarding the
postcentral gyrus in PTSD populations. Decreased response inhibition was found to be
associated with activity in this area in veterans with PTSD (van Rooij et al., 2014).
While literature on the functional relationships of the areas identified as
significantly different between treatment completers and dropouts after attending is
abundant, reports of structural findings are not. A study by Lindemer and colleagues
(2013) found a significant negative correlation between PTSD symptom severity and
cortical thickness in the postcentral gyrus in veterans with PTSD, indicating that reduced
gray matter is associated with increased severity of symptoms. As such, interpretation of
the findings of the current study must be tempered with consideration of the lack of
robust structural findings thus far.
Results from the current study begin to establish a basis for understanding
structural abnormalities across individuals with PTSD and how this influences the
application of treatment. The aforementioned functional studies can provide an
elementary context for interpretation of the findings between the treatment completion
group and individuals that subsequently dropped out of treatment after attending a
session. With regard to these functional studies, it appears that the two groups may be
predisposed to different responses to CPT that are associated with structural variations,
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under the general assumption that increased functional activity of an area is related to
neuronal proliferation and vice versa. For example, treatment completers exhibited
reduced gray matter in the precentral gyrus, an area where increased activity is thought to
be related to increased cognitive control. Thus, the application of CPT, which promotes
healthy top-down regulation, may have been more amenable to treatment completers who
were lacking such skills prior to treatment. Alternatively, treatment dropouts after
attending the initial session may have already been over-engaged in the cognitive
regulation of their emotions. Addressing “stuck points” and experiencing emotions
associated with their traumatic memories may not have been as useful or appealing to this
group for this reason.
The excessive cognitive regulation of emotion in treatment dropouts may have
also been occurring in the presence of increased PTSD symptom severity and reduced
PA, which were significantly different between the groups. However, previous research
indicated that greater PTSD severity is associated with reduced cortical thickness of the
postcentral gyrus (Lindemer et al., 2013). Treatment dropouts after attending exhibited
increased volume in this area, despite their experience of more severe symptoms than
their completer counterparts. The present results suggest that this result may not hold true
within a PTSD group, given the extreme heterogeneity and variable symptom
presentations of clinically significant PTSD. Future studies should examine the
differences in symptom profiles of PTSD and how these differences may relate to
observed variations in brain structures. These efforts may help clarify frequent
inconsistencies observed in both structural and functional findings related to PTSD.
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Between PTSD Treatment Groups and Healthy Controls
This project has been the first to examine gray matter abnormalities as an
indicator of CPT treatment completion for PTSD. As such, the group results presented
may be discordant with previous bodies of literature comparing a PTSD group to some
sort of control group. Given the presence of a healthy control group in this study, group
trends in gray matter volume were also explored between the entire PTSD group and
healthy controls. Interestingly, there were no significant differences between the groups
that survived the correction for multiple comparisons. However, this may result may have
been a product of the heterogeneity previously observed within the PTSD treatment
groups. Specific group comparisons were then conducted to see if this was the case. The
results indicated that gray matter volumes within the PTSD treatment completion group
were not significantly different from healthy controls. This finding suggests that gray
matter abnormalities in general may impede the application of CPT. Individuals who do
not exhibit these structural changes may be more amenable to CPT-based skills. The
absence of gray matter abnormalities in this subset of individuals may be related to the
specific aspects of individual traumatization and manifestation of pathology including
trauma type, chronicity, symptom severity, or comorbid affective problems.
Whereas there were no significant differences in brain volume between
participants who dropped out of treatment before attending a session and healthy
controls, numerous significant differences in gray matter were observed between
participants who dropped out of treatment after initially attending and the healthy control
group. Treatment dropouts exhibited significantly increased gray matter in the left
superior frontal cortex, right precuneus, and the left calcarine in comparison to the
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control group. Of these areas, functional connectivity studies have indicated reduced
activity to the right precuneus in individuals with who experience early life stress (Philip
et al., 2013). Alternatively, increased activity to the right precuneus during functional
connectivity analyses has also been observed in natural disaster survivors with PTSD
(Wu et al., 2011; Yin et al., 2011). Reduced gray matter volumes have been observed in
the right precuneus in adolescents with PTSD as well (Ahmed et al., 2012). Increased
activity in the right precuneus in individuals with PTSD has been linked to a sensitivity to
stimuli encoded in emotional contexts (Whalley et al., 2009). A positron emission
tomography investigation found decreased activity in the right precuneus in individuals
who responded to pharmacotherapy for anxiety (Carey et al., 2004). Concordant with this
finding, the current project implicates the right precuneus as an area of interest for
treatment completion in PTSD.
The last significant finding of the analysis indicated increased gray matter volume
in the left superior frontal cortex in PTSD treatment dropouts versus healthy controls.
This finding is difficult to interpret, since it is a large region with numerous proposed
functions. Generally speaking, this area is thought to be important for the top-down
regulation of emotion. However, both increased (van Rooij et al., 2014) and decreased
(Wu et al., 2011) activation has been observed in the superior frontal gyrus of PTSD
participants in response to multiple tasks over several studies in comparison to healthy
controls. Studies of gray matter volumes are beginning to converge on similar
conclusions. For example, reduced gray matter volume was observed in the right superior
frontal gyrus in PTSD participants compared to trauma exposed controls (Li et al., 2014).
Qi and colleagues (2013) also suggest that cortical thinning in this region is associated
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with increased PTSD symptom severity. However, the present findings appear
inconsistent with this suggestion, as the PTSD treatment dropout group exhibited greater
gray matter volume in this area relative to healthy controls.
Affectivity and Structural Findings
The final structural analysis of this project sought to examine the relationship
between affectivity and emotional areas related to PTSD. NA demonstrated a significant
positive association with gray matter in the right parahippocampus, even after controlling
for BDI scores. As previously mentioned, the parahippocampus has been established as a
brain region of interest in the study of PTSD. However, this was the only region with
which NA was significantly associated. This result is intriguing, given the established
relationship between NA and PTSD symptoms. One possible explanation is that selfreported NA does not represent a viable proxy for broad structural abnormalities
associated with PTSD. This would infer measurement error with self-report as a method
to assess symptoms. The issue could also be timing. Participants were reporting their
experience of NA over the ‘past few weeks.’ Perhaps the subjective perception of current
distress is not representative of structural changes that may occur over longer periods of
time. As such future studies should not rule out the absence of such relationships, and
functional imaging studies should explore whether or not NA influences temporal
emotion regulation.
It was also predicted that PA would be inversely related to gray matter volume in
areas related to emotion regulation. However, results indicated that PA was positively
associated with volumes in the medial prefrontal cortex (mPFC; Brodmann Area 10) and
right precuneus, and these relationships remained significant even after controlling for
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symptoms of depression. The mPFC is generally implicated as an area important for the
top-down regulation of emotion and is hypoactive in individuals with PTSD. These
results suggest that, as PA increases, so does brain volume in this area. Treatment
implications for this finding include the initial use of behavioral activation strategies at
the outset of treatment for individuals with low PA to improve their overall regulation of
distress. This implication also fits with the previous observation that PA was one of the
clinical variables that was significantly different between treatment completers and
dropouts. These results also suggest that individuals with PTSD may be better at
reporting deficits in PA than excesses in NA, since PA may be a better proxy for
structural alterations in this population.
Functional Results
Bruce and colleagues (in preparation) recently observed that CPT facilitates the
normalization of emotional processing during the conflict task in participants treated for
PTSD. The final hypothesis of this study examined how the relationship between
affectivity and emotional processing during the conflict task changed from pre-treatment
to post-treatment. Four primary conditions of the task were observed: AF, IF, AN, IN.
Pre-treatment Functional Results
When attention was oriented to fearful faces, self-reported NA was found to be
inversely correlated with brain activation in the right calcarine and the left superior
frontal cortex, such that increased NA prior to the administration of CPT is associated
with decreased activation in these regions. PA was also positively associated with
activation in the left postcentral gyrus during this condition. While ignoring fearful faces,
PA was inversely associated with activation in the left parahippocampal gyrus.
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Participants generally reported lower levels of PA at pre-treatment, which would infer
greater activation in this area. The other significant findings at pre-treatment were
between PA and activation during the ignoring of neutral faces condition. PA was found
to be positively associated with activation in the right frontal inferior orbital cortex. In
what appears to be a common finding to the ignore conditions, PA was also inversely
associated with brain activation in the bilateral parahippocampal gyrus. No significant
findings were observed within the attending to neutral faces condition.
It appears that decreased activation in the calcarine cortex is related to the
abnormal processing of faces in some clinical populations. For example, Petrowski and
colleagues (2014) found that patients with panic disorder and agoraphobia exhibited
deactivation of this region in response to emotionally neutral faces in comparison to a
healthy control group. While the current finding was observed within the attention to
fearful faces condition, high levels of NA related to anxiety disorders and PTSD may
imply a disruption of functioning in the calcarine. This disruption may be exaggerated
when processing facial stimuli that are perceived as distressing, such as the fearful faces
of the conflict task. Likewise, high levels of NA at pre-treatment were associated with
reduced functioning in the left superior frontal cortex, an area thought responsible for
domains of cognitive control.
The present findings also suggest that activity in the parahippocampal gyrus may
be associated with abnormal processing of positive emotions when participants are tasked
with ignoring both neutral and emotionally-valenced stimuli. Previous fMRI research
using a paradigm to invoke positive emotional processing found that control subjects
recruited the parahippocampal gyrus more so than the PTSD group (Jatzko et al., 2006).
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The authors concluded that these findings may be related to emotional numbness in
PTSD. The current results conflict with this previous finding in that lower positive affect
was generally associated with increased activation of this area. However, the current
paradigm does not explicitly invoke positive emotional processing. While the area may
indeed be important for the processing of positive emotions, the area has also been
implicated in episodic memory recall and flashbacks (Whalley et al., 2013) and assault
exposure and PTSD symptom severity (Cisler et al., 2013). As such, fear processing may
recruit this area in a different manner than positive emotion processing. Another
interpretation is that increased activation of this area is associated with the normal
processing of positive emotions, similar to the control sample in the Jatzko et al. (2006)
study. Thus, while the sample reported generally low levels of PA, they continued to
process positive emotions appropriately. As such, increased activation of this area may
reflect a biomarker for resilience and treatment completion.
The final pre-treatment functional finding involved a positive association between
PA and activation of the right frontal inferior orbital cortex. Low levels of PA at pretreatment were thus associated with deactivation in this area during the ignoring of
neutral faces condition. Previous research has identified emotional processing deficits in
this region in individuals with PTSD, particularly during symptom provocation and
exposure to traumatic reminders (Bremner, 1999). Another study observed increased
spontaneous activity in the orbital cortex in veterans with PTSD in comparison to control
subjects (Yan et al., 2013). Tarquis (2006) suggests that the orbital cortex plays an
important role in the identification of fearful contexts and the anticipation of danger. The
orbital frontal cortex projects to the limbic system and is thought to be important for
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decision-making and the top-down regulation of emotion. The present findings imply that
increasing PA may also influence the efficiency of conscious decision making and the
regulation of emotional responses, particularly in the presence of trauma symptom
provocation.
Post-treatment Functional Results
At post-treatment, participants reported significantly lower levels of NA and
significantly greater levels of PA than at pre-treatment. This change reflected some
interesting associations with brain activation during the conflict task after the completion
of CPT. During the attention to fearful faces condition, self-reported PA was inversely
associated with activation in the left postcentral gyrus, left fusiform, right precentral
gyrus, and right precuneus. Higher scores of PA are thus indicative of lower activation in
these regions in PTSD participants. Contrary to the pre-treatment findings during
attention to fear, NA was not significantly associated with activation in any brain region.
Significant findings were also observed during the attention to neutral faces condition.
NA was found to be inversely associated with activation in the right middle orbitofrontal
cortex and right superior frontal cortex. Lower scores at post-treatment are related to
increased activation in these regions. PA was also found to be positively correlated with
activation in the left superior frontal cortex such that higher scores are associated with
increased activation in this area. During the ignoring of fearful faces condition, PA was
significantly associated with increased activation in the right middle frontal cortex.
Some post-treatment relationships between brain activation and affectivity in CPT
treatment completers are suggestive of normalized emotional processing. During the
attention to fearful faces condition, higher PA scores were associated with lower
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activation in the left postcentral gyrus, right precentral gyrus, left fusiform gyrus, and the
right precuneus. With regard to these particular regions, previous research suggests that
individuals with untreated PTSD exhibit greater activation in the left postcentral gyrus
than healthy controls during a task of response inhibition (van Rooji et al., 2014). Similar
results utilizing this task were observed in the precentral gyrus as well (Falconer et al.,
2008). Concordant with these findings, decreased activation in these regions during the
emotionally-valenced attention to fearful faces condition may reflect improvements in
inhibitory control in the current sample. Increased activation of the fusiform during the
viewing of fearful distractors has also been observed in untreated individuals with PTSD
(Zhang et al., 2013). Greater PA in treatment completers was associated with decreased
activation of the fusiform in the presence of fearful faces. Additionally, increased activity
to the right precuneus during functional connectivity analyses was observed in natural
disaster survivors with PTSD (Wu et al., 2011; Yin et al., 2011). Reduced activity in this
area may be indicative of normalization of brain function in this region.
Perhaps the most interesting results from pre-treatment to post-treatment involve
the relationship between activity in the left postcentral gyrus and PA. At pre-treatment, a
positive association was observed such that low levels of PA were related to decreased
activation in this region during the attention to fear condition. At post-treatment, the
opposite relationship was observed, such that higher levels of PA were related to lower
activation in this region. First and foremost, this was the only region to remain
significantly associated with an affective dimension within the task across treatment. A
study by van Rooji and colleagues (2014) found that reduced inhibition of the postcentral
gyrus was associated with individuals with PTSD in comparison to trauma-exposed and
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healthy controls during a task of reactive inhibition. Thus, increased activity in this
region may represent a biomarker for dysregulation in reactive inhibition. As such, the
present results suggest that activation remains reduced in this region from pre-treatment
to post-treatment. It is possible that appropriate inhibition of this structure may act as a
predictor of treatment completion, independent of the experience of PA.
During the presentation of the pre-treatment results, the superior frontal and
middle frontal orbital cortices were discussed as areas important for inhibitory control.
During the attention to fearful faces condition at pre-treatment, high NA was associated
with deactivation in the left superior frontal cortex. Similarly, low PA was associated
with deactivation in the middle frontal orbital cortex during the ignoring of fearful faces
condition at pre-treatment. However, an increased BOLD response in these and related
regions during the attention to neutral faces condition at post-treatment was observed as
associated with lower scores of NA. While causality between NA and increased
activation in these regions cannot be determined, it can be said with confidence that NA
significantly decreased over the course of treatment. Changes in this self-reported
dimension or changes in neurobiological emotion processing mechanisms as a result of
CPT may reflect the improvements in emotional processing observed at post-treatment in
this sample. As mentioned previously, increased activation of these areas is generally
associated with the efficient top-down regulation of emotion.
Positive associations between PA and increased activation in the left superior
frontal cortex during the attention to neutral faces condition and the right middle frontal
cortex during the ignoring of fearful faces condition were also observed at post-treatment.
These areas have several proposed functions within PTSD including non-conscious fear
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processing (Bruce et al., 2012) and processing of positive emotional stimuli (Jatzko et al.,
2014). Jatzko and colleagues (2014) reported increased activation in the superior frontal
gyrus in PTSD participants relative to healthy controls during the processing of movieinduced positive emotions and suggest that this alteration in functioning may be related to
emotional numbness in PTSD. The present findings differ from that presented by this
previous study, as increased PA was associated with an increased bold response in that
region, though not bilaterally, during both attention and ignore conditions. Taken
together, the present study and the study by Jatzko and colleagues suggest a complex
relationship between functioning of the superior frontal cortex and the experience of
positive emotion in individuals with PTSD. While this area may indeed relate to
emotional numbing in participants with PTSD, directionality is difficult to interpret, as
few studies have examined the relationship between PA and this area as it relates to
positive emotional processing.
There are several possible interpretations for the discrepancy between the Jatzko
et al. study and the current project. First, the studies examined this region within the
context of very different tasks: one elicited positive emotion processing, the other
examined the relationship between self-reported PA and emotional processing during a
task of affective induction. Another possible reason for the differences is that the current
project only examined relationships between activation and affectivity in PTSD treatment
completers who were also survivors of interpersonal trauma. As such, the present finding
may only pertain to a specific sample of individuals. However, the analysis was
necessary, as these relationships may provide insight to increasing the efficiency of CPT
with interpersonal trauma survivors. Lastly, the relationship between the complex series
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of regional interactions that constitute positive emotional processing and the task utilized
by Jatzko et al. is questionable. Participants watched a well-known movie clip that may
surely induce positive emotion, but does this clip actually go further and solicit positive
emotional processing involving areas related to cognition in the prefrontal regions?
Future research directions for the examination of this area involve understanding the
specialized functions of the superior frontal gyrus as it relates to positive emotional
processing and how these functions vary across different populations and experimental
conditions.
Limitations
There are some limitations of the current project worth noting. The first limitation
is the unequal number of subjects between the PTSD group and the healthy control
group. Power of a between-group analysis is based on the size of the smaller group (n =
15), which may have limited the detection of significant group differences in this project.
While this did not appear to be an issue with regard to self-reported clinical variables,
insufficient power may have limited findings of the fMRI group analyses between PTSD
participants and healthy controls. The second limitation is the relative homogeneity of the
healthy control group. The healthy control group was significantly more educated and
primarily composed of Caucasian participants in comparison to the PTSD group. While
the racial composition of the groups was not significantly different, the PTSD group
appears much more diverse than the control group. In addition, only within-group time 2
analyses were possible because the healthy control group did not receive a time 2 scan or
assessment. As such, there was no comparison condition for time or treatment to the
administration of CPT. However, the primary aim of this project was to examine the
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interaction between affectivity and the administration of CPT, which was feasible using a
within-subjects pre-treatment/post-treatment design.
Other limitations concern the PTSD group. The group was comprised primarily of
female interpersonal trauma survivors who received CPT. Results from this project may
not generalize to males, individuals afflicted by other types of trauma, or individuals
receiving another variant of trauma-focused therapy. As previously mentioned, power
was also an issue when conducting within-group comparisons of participants with PTSD.
Of the 38 participants originally enrolled in treatment, 24 successfully completed therapy
and 14 participants did not. Examination of group differences between therapy
completers and all therapy dropouts presented less of an issue than examining the
completers in comparison to two distinct dropout groups: those who attended at least one
session of CPT (n = 9) and those who dropped out before CPT began (n = 5). While
power does not present an issue for significant differences that are detected, it does limit
the ability of the analysis to detect smaller effects. Thus, the within-group PTSD analyses
should be interpreted with caution. However, such an analysis was necessary to examine
the impact of clinical and neurobiological dimensions on CPT treatment completion and
was somewhat constrained by the relative success of CPT treatment completion (63%) in
this sample. Additionally, all participants enrolled in the original ITT sample who
dropped out of treatment were included in the dropout group, regardless of the
circumstances surrounding their termination of services.
Limitations were also inherent to the design of the conflict task. During the
experimental condition or affective induction, the task displays primarily fearful faces.
While an argument could be made that these images likely invoke both fear circuitry and
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affect dysregulation systems, the incorporation of other negative faces could serve as
important comparison conditions. The task does indeed facilitate emotional processing
and attentional resources, but it may have not been optimal for the examination of the
broad-based emotional dimensions NA and PA. Additionally, the use of neutral faces as
the comparison condition may have been confounded by the tendency for PTSD
participants to interpret these faces negatively. Previous research on the viewing of
neutral stimuli demonstrated that participants with depressive symptoms were more likely
to perceive the stimuli as negative (Nejad et al., 2013).
A final limitation of note is the sensitivity of the ROI analyses in this project.
Generally speaking, an ROI mask that specifies only a few brain regions is much more
sensitive at detecting differences in those areas. However, given the multitude of brain
regions implicated in both the fear circuitry and affect dysregulation models of PTSD that
are of interest in this project, the ROI mask was quite broad, consequentially expanding
the number of multiple comparisons in both the structural and functional analyses. As
such, the error correction for multiple comparisons was quite stringent, requiring a
particularly large voxel number to achieve statistical significance. With this constraint, it
is possible that important differences in both brain structure and function in smaller brain
regions were overlooked after failing to meet the significance criterion following the
correction for multiple comparisons. Thus, ROIs that exhibited null findings in this
project should not be dismissed as unimportant to affect regulation in individuals with
PTSD.
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Summary and Conclusions
CPT has demonstrated robust efficacy in the treatment of PTSD. While treatment
dropout occurs, it is perceived to be inevitable in some cases and a result of individual
client factors. An alternative hypothesis is that our evidenced-based treatments are not
meeting the needs for clients with clinically significant impairment. The fact remains that
some individuals drop out of treatment and remain symptomatic with suboptimal
functioning. The next step in the development of established evidence-based approaches
for PTSD is to examine this population with consideration of the active components of
the treatment to improve treatment implementation and effectiveness. This can be done
by examining the interaction between treatment implementation and individual client
variables.
Of the many possible client variables of interest that may influence dropout (i.e.,
race, SES, marital status), those most affected by the treatment process are clinical
variables and dimensions of functioning. The present study attempted to examine the
interaction of self-reported latent constructs (i.e., affectivity) and neurobiological
constructs within the application of CPT. While it was found that CPT can improve selfreported affectivity for individuals that remain in treatment, it appears that low PA in
particular may represent a risk factor for dropout from CPT. Additionally, gray matter
volume in some areas related to the top-down regulation of emotion was also found to be
significantly different between the treatment completion and dropout groups. In
conjunction, these results suggest that there is more work to be done in identifying
clinically relevant client variables that influence the application of manualized treatments
for PTSD. This research could provide the foundation for a clinical assessment protocol
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that identifies individual risk factors for treatment adherence and dropout, allowing the
subsequent treatment plan to be tailored for specific client needs. This may ultimately
enhance the effectiveness of manualized treatments.
However, conducting an MRI scan on every treatment seeker is currently both
impractical and expensive, which creates the demand for a means to approximate
neurobiological structural and functional biomarkers of treatment. Exploration of clinical
variables related to neurobiological dimensions is essential in this context. It is possible
that within-group differences in gray matter may reflect differences in measurable
clinical variables, including affectivity, individual PTSD symptom profiles, or symptom
severity. Future analyses of this data will examine the relationships between other clinical
variables of interest as they relate to variations in brain structure and function in this
particular sample.
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Table 1. Demographic characteristics of the PTSD and control participants at pretreatment presented as Mean (standard deviation) or number (%).
Characteristic
PTSD (n = 38)
Controls (n = 15) F, Χ2
p
Age (years)
30.78 (9.21)
33.40 (11.38)
0.750
0.391
Gender (female)
38 (100%)
15 (100%)
Race (AA, CAU)
9 (24%), 23
2 (13%), 13
2.658
0.447
(61%)
(87%)
Education (years) 15.32 (2.21)
17.27 (3.13)
6.190
0.016
Right Handed
38 (100%)
15 (100%)
BDI Total Score
24.26 (11.00)
4.20 (3.16)
32.126
<0.001
PDS Total Score
28.44 (10.34)
3.92 (5.70)
60.751
<0.001
NA Total Score
28.84 (8.63)
14.93 (3.94)
35.727
<0.001
PA Total Score
23.68 (7.51)
37.87 (6.90)
40.119
<0.001
Note: PTSD = Posttraumatic Stress Disorder, AA = African American, CAU =
Caucasian, BDI = Beck Depression Inventory, PDS = Posttraumatic Diagnostic Scale,
NA = Negative Affect, PA = Positive Affect
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Table 2. Pearson product-moment correlations between study variables at pre-treatment.
1
1.Negative Affect

2

3

4

5

-0.26

3.CAPS Total Score

0.54**

-0.40ϯ

-

4.PDS Score

0.54**

-0.50*

0.62**

-

5.BDI Score

0.57**

-0.60**

0.64**

0.84**

6.Age

0.26

-0.16

0.13

0.23

0.13

7.Education

0.17

0.08

0.09

-0.23

-0.24

*p<0.01

7

-

2.Positive Affect

ϯ p<0.05

6

**p<0.001

-

0.14

-
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Table 3. Pre-treatment and post-treatment clinical variables in PTSD treatment
completers (n = 24)
Characteristic
Pre-treatment
Post-treatment
F, Χ2
p
CAPS Total Score 68.95 (20.95)
26.58 (22.03)
85.906
<0.001
BDI Total Score
21.11 (11.30)
9.84 (9.22)
36.591
<0.001
PDS Total Score
24.16 (10.18)
10.47 (10.11)
40.225
<0.001
NA Total Score
28.32 (9.85)
19.58 (8.11)
17.044
0.001
PA Total Score
25.00 (7.18)
30.16 (7.80)
9.863
0.006
Note: PTSD = Posttraumatic Stress Disorder, CAPS = Clinician Administered PTSD
Scale, BDI = Beck Depression Inventory, PDS = Posttraumatic Diagnostic Scale, NA =
Negative Affect, PA = Positive Affect
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Table 4. Pearson product-moment correlations between study variables at posttreatment.
1
1.Negative Affect

2

3

4

5

-0.30

3.CAPS Total Score

0.80**

-0.39

-

4.PDS Score

0.76**

-0.38

0.84**

-

5.BDI Score

0.71**

-0.30

0.78**

0.78**

6.Age

0.19

-0.21

0.32

0.23

0.22

7.Education

0.01

0.43

-0.02

0.07

0.01

*p<0.01

7

-

2.Positive Affect

ϯ p<0.05

6

**p<0.001

-

0.14

-
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Table 5: Treatment Completers vs. Treatment Dropouts before Attending
Region

MNI
coordinate
(-24, -27, -26)

Cluster
size
331

Z

Direction

L parahippocampal gyrus
3.66
T>D
L entorhinal cortex
R entorhinal cortex
(23, -12, -33)
369
3.34
T>D
R parahippocampal gyrus
Note: T = Treatment, D = Dropout, MNI = Montreal Neurological Institute, L = left, R =
right.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Table 6: Treatment Completers vs. Treatment Dropouts after Attending
Region

MNI
Cluster
Z
Direction
coordinate
size
L supplementary motor area
(0, -1, 64)
761
3.80
T<D
R supplementary motor area
(2, -22, 61)
L postcentral gyrus
(-21, -31, 58)
378
3.75
T<D
L precentral gyrus
(-29, -24, 57)
R calcarine
(18, -67, -14)
1053
3.53
T<D
L calcarine
(0, -64, 15)
R calcarine
(6, -70, 18)
Note: T = Treatment, D = Dropout, MNI = Montreal Neurological Institute, L = left, R =
right.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Table 7: Dropout after Attending vs. Healthy Controls
Region

MNI
Cluster
Z
Direction
coordinate
size
L superior frontal cortex
(-27, -9, 58)
273
3.79
D>C
R precuneus
(11, -69, 30)
2455
3.72
D>C
R superior occipital cortex
(21, -67, 32)
L middle cingulate
(-12, -51, 32)
L calcarine
(-8, -91, -9)
388
3.60
D>C
(-11, -100, -2)
(-3, -96, 3)
Note: D = Dropout, C = Controls, MNI = Montreal Neurological Institute, L = left, R =
right.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Table 8: Structural Regression Results
Region

Group

R parahippocampus
R parahippocampus

R middle frontal
gyrus
R precuneus

R precuneus

R superior medial
frontal gyrus
R middle cingulate
L middle cingulate
L middle frontal
gyrus
L superior medial
frontal gyrus
L superior frontal
gyrus
L medial frontal
orbital gyrus
R medial frontal
orbital gyrus
L postcentral gyrus

Cluster
size
428

Z

Variable

Direction

PTSD
PTSD
PTSD
PTSD
PTSD
PTSD

MNI
coordinate
(18, -3, -29)
(20, -21, -24)
(21, -18, -27)
(26, 3, -33)
(20, -3, -32)
(41, 51, 4)

3.63

NA

Positive

466

3.78

NA*

Positive

366

3.90

PA

Positive

PTSD
PTSD
PTSD
PTSD
PTSD
PTSD
Control

(3, -64, 37)
(11, -60, 40)
(6, -58, 30)
(45, 47, 3)
(8, -58, 28)
(2, -61, 37)
(11, 42, 36)

958

3.53

PA

Positive

777

3.94

PA*

Positive

333

4.25

NA

Negative

Control
Control
Control
Control
Control

(6, 23, 39)
(8, 33, 42)
(-3, -22, 45)
(-12, -19, 45)
(-26, 45, 33)

338

3.54

NA

Negative

273

3.50

NA

Negative

Control

(-9, 50, 27)

Control

(-17, 44, 30)

Control

(-5, 60, -3)

375

3.28

NA

Negative

Control

(2, 47, -11)

Control (-51, -18, 37) 305
3.99 PA
Positive
Control (-51, -16, 30)
Control (-47, -22, 51)
Note: PTSD = Posttraumatic Stress Disorder, MNI = Montreal Neurological Institute, L =
left, R = right, PA = Positive Affect, NA = Negative Affect.
* Denotes analysis that controlled for depression symptoms.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Table 9: Pre-treatment fMRI Regression Results
Region

L superior frontal
gyrus

Task
MNI
Conditio coordinate
n
AF
(-14, 42, 30)

R calcarine

AF

L postcentral gyrus

AF

L parahippocampus
R frontal inferior
orbital

IF
IN

(-16, 50, 26)
(-26, 54, 22)
(22, -62, 6)
(22, -72, 12)
(-18, -32, 70)
(-32, -38, 68)
(-22, -40, -8)
(44, 36, -6)

Cluster
size

Z

Variable

Direction

189

3.54

NA

Negative

180

3.48

NA

Negative

153

3.52

PA

Positive

126
338

4.08
4.35

PA
PA

Negative
Positive

(52, 24, -6)
L parahippocampus
IN
(-28, -40, -8)
266
4.35 PA
Negative
(-32, -44, -14)
R parahippocampus
IN
(28, -38, -8)
128
3.67 PA
Negative
Note: MNI = Montreal Neurological Institute, L = left, R = right, PA = Positive Affect,
NA = Negative Affect.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.
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Table 10: Post-treatment fMRI Regression Results
Region
R middle frontal orbital
gyrus

Task
Condition
AN

MNI coordinate
(36, 54, -12)

Cluster
size
144

Z
3.85

Variable

Direction

NA

Negative

(26, 50, -12)
(30, 46, 10)
119
3.37
NA
(28, 50, 20)
AN
(-14, 42, 32)
161
3.69
PA
(-10, 38, 40)
L postcentral gyrus
AF
(-44, -22, 56)
310
4.38
PA
(-56, -16, 42)
(-44, -22, 40)
R precentral gyrus
AF
(28, -26, 70)
1174
4.15
PA
(52, -8, 50)
R middle cingulate
(8, -16, 42)
L fusiform
AF
(-34, -30, -26)
314
3.81
PA
(-32, -28, -18)
L parahippocampus
(-24, -26, -24)
R precuneus
AF
(10, -58, 56)
238
3.51
PA
L middle cingulate
(-2, -44, 52)
L precuneus
(-10, -44, 64)
R middle frontal gyrus
IF
(20, 54, 28)
155
3.58
PA
(12, 54, 34)
Note: MNI = Montreal Neurological Institute, L = left, R = right, PA = Positive Affect,
NA = Negative Affect.
R superior frontal gyrus
R middle frontal gyrus
L superior frontal gyrus

AN

Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.

Negative
Positive
Negative

Negative

Negative

Negative

Positive
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Figure 1
Conflict Task Depiction
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Figure 2
Region of Interest (ROI) Mask
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Figure 3
Gray Matter Differences between the Treatment Completion and No-show Groups

Note: L = left, R = right.
Note: Findings indicate greater volumes in treatment group.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Figure 4
Gray Matter Differences between the Treatment Completion and Dropout Groups

Note: L = left, R = right.
Note: Findings indicate reduced volumes in treatment group.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Figure 5
Gray Matter Differences between the Treatment Dropout and Control Groups

Note: L = left, R = right.
Note: Findings indicate greater volumes in treatment dropout group.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Figure 6
Association between Affectivity and Gray Matter Volume in PTSD Participants

Note: L = left, R = right, PA = Positive Affect, NA = Negative Affect.
Note: All observed relationships represent positive associations.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Figure 7
Association between Affectivity and Gray Matter Volume in Control Participants

Note: L = left, R = right, PA = Positive Affect, NA = Negative Affect.
Note: Observed relationships with NA represent negative associations. Observed
relationship with PA represents a positive association.
Note: All structural analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 271 and an uncorrected p <
.005.
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Figure 8
Pre-treatment Association between Affectivity and Activation during Attend Fear
Condition

Note: L = left, R = right, PA = Positive Affect, NA = Negative Affect.
Note: Observed relationships with NA represent negative associations. Observed
relationship with PA represents a positive association.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.
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Figure 9
Pre-treatment Association between PA and Activation during Ignore Fear Condition

Note: L = left, R = right.
Note: Observed relationship with PA represents a negative association.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.
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Figure 10
Pre-treatment Association between PA and Activation during Ignore Neutral Condition

Note: L = left, R = right, (+) = Positive Relationship, (-) = Negative Relationship.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.
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Figure 11
Post-treatment Association between PA and Activation during Attend Fear Condition

Note: L = left, R = right.
Note: All observed relationships with PA represent negative associations.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.
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Figure 12
Post-treatment Association between PA and Activation during Ignore Fear Condition

Note: R = right.
Note: Observed relationship with PA represents a positive association.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.
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Figure 13
Post-treatment Association between Affectivity and Activation during Attend Neutral
Condition

Note: L = left, R = right, PA = Positive Affect, NA = Negative Affect.
Note: Observed relationships with NA represent negative associations. Observed
relationship with PA represents a positive association.
Note: All functional analyses were considered significant and corrected for multiple
comparisons at a combined voxel extent threshold of k = 116 and an uncorrected p <
.005.

